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Kyung-Min Chung, PhD 
University of Connecticut, 2015 
Abstract 
Forced ectopic expression of the transcription factors OCT4, SOX2, KLF4, and c-
MYC (OSKM) can directly reprogram various somatic cells into induced pluripotent stem 
cells (iPSCs). These reprogrammed cells offer great potential as a source for patient-
matched regenerative therapies thanks to their striking molecular and phenotypic 
similarity to embryonic stem cells. However, despite years of research, this process 
remains highly inefficient and produces considerable cellular heterogeneity. Moreover, 
long latency has stalled the effort to understand the mechanisms and molecular 
changes underlying the reprogramming process. To improve and facilitate the 
development of efficient and rapid reprogramming strategies, a clear understanding of 
fundamental reprogramming mechanisms is essential. 
In this work, we use single-cell transcript profiling, fluorescence-activated cell 
sorting (FACS), and mathematical modeling to provide a precise mathematical 
framework describing the dynamics of pluripotency gene expression during 
reprogramming by OSKM. Additionally, we generated a reprogramming progression 
axis that precisely measures the progression of individual cells towards pluripotency. 
We found that the stochastic phase of reprogramming is an ordered probabilistic 
process with independent gene-specific dynamics. Furthermore, we demonstrated that  
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polycistronic viral (OSKM) delivery produces significantly higher reprogramming 
efficiencies as compared to monocistronic delivery, due to premature inactivation of the 
individual O, S, K, or M vectors in the monocistronic method. Finally, we show that the 
order of gene activation is similar in two fibroblast cell types, MRC-5 and BJ, and that 
these two cell types take divergent paths upon reprogramming factor induction, followed 
by convergence later in the reprogramming process.  
The results of our work emphasize the important value of precise mathematical 
modeling and of the reprogramming progression axis in understanding fundamental 
reprogramming mechanisms. This work lays the foundation for the measurement and 
mechanistic dissection of treatments that enhance the rate or efficiency of 
reprogramming to pluripotency. 
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Chapter 1 Introduction 
1.1 Somatic Reprogramming 
Various mammalian somatic cells can be reprogrammed to induced pluripotent stem 
cells (iPSCs) through ectopic expression of four individual transcriptional factors – 
OCT4, SOX2, KLF4, and c-MYC (OSKM) [1] and allow the direct modeling of human 
disease, ultimately offering the potential to revolutionize regenerative medicine[2]. Since 
their discovery by Yamanaka in 2006, reprogramming techniques have been 
comprehensively studied, with reprogramming translated from mouse adult fibroblasts 
[1,3,4] to various human adult fibroblasts [1,5,6], including adipose stem cells [7], 
mature B cells [8], stomach and liver cells [9], neural stem cells [10,11], melanocytes 
[12], pancreatic  cells [13], and keratinocytes [14] indicating that these techniques have 
a seemingly universal capacity to change cellular identity. However, even with their 
tremendous potential for reprogramming various cell types, reprogramming techniques 
have been hindered by stochastic, extreme heterogeneity, and a nonspecific 
reprogramming process, which resulted in low reprogramming efficiency (0.001% to 
1%) [1,15]. In addition, generating iPSCs through conventional methods raises 
concerns about their use in clinical applications, due to virus-mediated gene delivery 
that results in genomic integration of the four exogenous reprogramming factors and the 
natural function of c-MYC as an oncogene [16]. 
1.1.1 Various somatic reprogramming methods addressing clinical safety 
To overcome these numerous reprogramming obstacles and clinical safety 
concerns, many improvements in methodology have been achieved through alternate 
transduction, such as episomal vector [17], adenoviral [18], Sendai vectors [19], 
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transient transfection [18], removable PiggyBac Transposon Vector System [20], and 
the minicircle system [21]. These methods address clinical safety concerns relating to 
the potential use of iPSCs in regenerative medicine by avoiding the integration of 
exogenous DNA and the permanent introduction of oncogenes. However, the efficiency 
and kinetics of these methods remain extremely low compared to conventional vector-
integrating methods [22–24]. In addition, iPSCs have been generated using 
recombinant protein or synthetic mRNAs, but the protocols for doing so involves 
technical challenges and are expensive [25–28]. Furthermore, the addition of certain 
microRNAs (miR200, miR302, miR369) to OSKM factors can generate iPSCs more 
efficiently, but the concrete use and robustness of these methods remain unclear 
[29,30]. 
1.1.2 Various somatic reprogramming methods addressing reprogramming efficiency 
Along with addressing clinical safety concerns, many different methods have 
been developed to increase reprogramming efficiency. One such method uses different 
sets of transcriptional factors to generate iPSCs. For example, SOX1 and SOX3 can 
replace SOX2, KLF2 can replace KLF4, and L-MYC and N-MYC are able to replace c-
MYC in mice [16]. Additionally, using NANOG instead of KLF4 and LIN28A instead of c-
MYC with OCT4 and SOX2 (OSNL) can generate human iPSCs from human fibroblast 
cells [17]. Furthermore, the mesenchymal-epithelial transition (MET)-related gene CDH1 
can replace OCT4 in the OSKM cocktail in mice [31], and ectopic expression of 
chromatin-modifying genes, such as TET1, TET2, UTX, BRG1, and BAF155 
(SMARCC1) [32–34], can replace one of the four OSKM factors during reprogramming. 
Other unrelated pluripotency-associated transcriptional factors, such as the orphan 
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nuclear receptor ESRRB, can replace KLF4 [35], and the orphan nuclear receptor 
NR5A2 can replace OCT4 [33].  
Moreover, c-MYC reprogramming factors have been shown to be dispensable 
[16], and human and mouse neural stem cells that already express endogenous SOX2, 
KLF4, and c-MYC can only be reprogrammed with ectopic expression of OCT4 [11,25]. 
However, dispensing with any of the four OSKM reprogramming factors yields 
extremely low reprogramming efficiency compared to the four conventional factors are 
used [36].  
In addition to using a combination of various transcriptional factors to generate 
iPSCs, small-molecule compounds alone and with the four reprogramming factors can 
generate iPSCs and enhance reprogramming efficiency. These small-molecule 
compounds are comprised of the GSK3 inhibitor Kenpaullone [37], the DNA 
methyltransferase inhibitor 5-Azacytidine [38], the histone methyltransferase inhibitor 
BIX-01294 [11,39], the histone deacetylase inhibitor valproic acid [40,41], the 
MAPK/ERK inhibitor PD0325901 [42], and Vitamin C [43]. Unlike conventional 
integrating OSKM factors, which directly involve and target pluripotent-specific 
chromatin-remodeling complex in somatic cells [44,45], these small compounds 
indirectly initiate somatic reprogramming by mediating endogenous, non-pluripotent-
specific chromatin-remodeling complex in somatic cells [46]. As a result, the successful 
and robust induction of iPSCs by small-molecule compounds alone would 
fundamentally change the concept of somatic reprogramming. 
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In addition to small-molecule compounds and various transcriptional factors, the 
stoichiometric ratio between the four reprogramming factors (OSKM 3:1:1:1) [47] and 
the single polycistronic vector cassette that contains all four reprograming factors [48] 
increase somatic reprogramming efficiency. Furthermore, certain extracellular signaling 
pathways, such as the Wnt and TGF- pathways, are involved in the reprogramming 
process. For example, the inhibition of TGF- during MET transition by c-MYC [49,50] 
and the activation of Wnt/-catenin signaling are likely to enhance reprogramming by 
broadly activating various pluripotent genes [51]. However, the mechanistic role played 
by each of the pathways during reprogramming is still elusive and a subject of debate. 
These various iPSC-generating methods show that somatic reprogramming is 
complicated and involves many different steps, roadblocks, and pathways. Modifying 
each of the reprogramming steps may facilitate and increase reprogramming efficiency. 
1.2 Stages of and barriers to reprogramming 
During the reprogramming process, successful reprogramming cells are required to 
transition through key intermediate stages and reprogramming barriers, such as 
increasing cell cycle rate [52], downregulation of fibroblast markers [15], resetting the 
epigenetic landscape [45,53–55], acquisition of epithelial characteristics through the 
process referred to as the Mesenchymal Epithelial Transition (MET) [56], and activation 
of early and late pluripotent markers to establish the pluripotency network [57]. These 
barriers are rate-limiting factors and probably contribute to the long latency of the 
process and its low reprogramming efficiency. 
  5 
During early reprogramming, successful reprogramming cells must increase their 
proliferation rate and simultaneously decrease in size. These proliferative and 
morphological changes are complemented on the molecular level by the induction of the 
proliferation gene, the induction of chromatin modifiers, and the downregulation of 
fibroblast-related genes [45,56,58]. If reprogramming cells fail to induce cell proliferation 
and do not undergo the proper morphological changes, they either remain in fibroblast-
like stages or often undergo apoptosis, senescence, or cell-cycle arrest. Specifically, 
silencing of the apoptotic regulators P53 and P21 is observed in early reprogramming 
and depleting these regulators has been found to enhance reprogramming efficiencies. 
In addition, during proper reprogramming, somatic cells must exhibit dramatic 
epigenetic changes in histone modification and DNA methylation similar to an 
embryonic stem cell (ESC)-like state. Several small-molecule compounds that inhibit 
histone and DNA methylation increase reprogramming efficiency [46] and enhance 
expression of the chromatin-modifying associated gene in successful reprogramming in 
an early stage of the process [59], and have demonstrated that changes in the 
epigenetic landscape are required for proper reprogramming. Moreover, failed 
reprogramming cells generally do not activate the expression of chromatin modifiers.  
Embryonic stem cells (ESCs) have the characteristics of epithelial cells with tight 
intercellular interactions, and express the important epithelial gene E-cadherin [60]. 
Therefore, mesenchymal-like somatic cells must gain an epithelial characteristic during 
reprogramming. During the MET, the reprogramming cell undertakes coordinated 
changes in cell-to-cell and cell–to-matrix interactions [61] that result in gaining epithelial 
characteristics and losing mesenchymal characteristics.  
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In addition to these interactions, properly-functioning reprogramming cells also gain 
expression of epithelial-related genes, such as CDH1, and downregulate expression of 
mesenchymal-related genes, such as SNAI1 [61]. The MET is a critical early roadblock 
to reprogramming and it is likely to be a determinant of successful reprogramming. For 
example, inhibiting the TGF signaling pathway [62] and promoting bone morphogenic 
protein (BMP) signaling [63] to enhance reprogramming efficiencies.  
Furthermore, E-cadherin genes are upregulated during the MET and are critical to 
establishing and maintaining pluripotency [60]. The addition of CDH1 to the OSKM 
cocktail can greatly improve reprogramming efficiency by decreasing iPSC generation 
time[64]. Meanwhile, the disruption of CDH1 activity through antibody blocking 
significantly decreases reprogramming efficiency[65].  
The extracellular, but not intracellular, domain of CDH1 is sufficient to generate 
iPSCs with OSKM reprogramming factors[65]. While these and other findings suggest 
that the major function of CDH1 is to promote colony formation through the MET, it is 
currently the only factor capable of replacing OCT4 (a key transcriptional regulator) in 
the OSKM cocktail.  
After the acquisition of epithelial characteristics and the establishment of ESC-like 
colony formations, reprogramming cells initiate activation of early pluripotent genes and 
establish a pluripotency network through expression of the endogenous core pluripotent 
genes OCT4, SOX2, and NANOG [66]. Several studies have suggested that the key 
event in initiating the late hierarchical phase and in establishing the core pluripotency 
network involves activation of the endogenous pluripotent initiating factor SOX2, which 
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promotes the activation of a series of downstream genes that allow the cells to enter the 
pluripotent state [57]. 
However, if the reprogramming cells do not enter the hierarchical phase by not 
expressing endogenous SOX2 or do not maintain high expression levels of endogenous 
OCT4 and SOX2, these cells can relapse to an intermediate stage of reprogramming, 
which further decreases reprogramming efficiencies. Furthermore, before the cells 
establish and enter the core pluripotent network, they must silence exogenous OSKM 
DNA [4]. However, this finding has been called into question by the contrary findings of 
other studies [67]. 
Each of these processes is thought to be a key stage in or barrier to reprogramming 
methods, and the extent to which they respectively suppress or activate these 
responses is associated with higher reprogramming efficiency.  
1.3 Reprogramming progression assessments 
The progression of cells through the reprogramming process has been determined 
by observing the morphological structure of the cell, as well as the expression of 
pluripotent surface markers, such as SSEA4, Tra1-60, and alkaline phosphatase (AP), 
or other transcriptional markers, such as endogenous OCT4 and NANOG[68],[52],[69]. 
These standards are widely accepted for assessments of iPSCs. As adult somatic cells 
begin to reprogram, they change morphologically from stretched and motile cells into 
compact and polarized cells, followed by colony formation. These compact colonies 
have distinct borders and well-defined edges that are similar to embryonic stem cells, 
and are comprised of cells with large nuclei and scant cytoplasm [68]. Although a wide 
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arrange of colony morphologies results from somatic reprogramming and appears to be 
similar to embryonic stem cells, only a subset of these colonies is functionally and 
molecularly comparable to ESCs. Hence, looking at morphology alone does not 
accurately distinguish fully reprogrammed iPSCs from partially reprogrammed iPSCs, 
nor does it accurately measure the progression towards pluripotency. 
The progression of reprogramming cells can also be assessed through the 
expression of cell surface markers. In mice, fibroblast cells that are undergoing 
reprogramming pass through a series of cell states that are characterized by the 
expression of specific surface markers. Initially, the expression of the fibroblast marker 
Thy1 is lost, followed by the expression of the SSEA1 surface marker by day 3 (D3)[69]. 
Later in the reprogramming process, the pluripotency genes OCT4 and NANOG, as well 
as AP, are expressed; these are often used as markers of successful 
reprogramming[52]. Similarly, human reprogramming cells are marked by the loss of 
CD13 fibroblast markers, followed by SSEA3, SSEA4 (early), Tra1-81, and Tra1-60 
(late) expression[68]. These are the most common surface markers that are widely used 
to distinguish human-induced pluripotent stem cells (hiPSCs). Furthermore, recent 
studies have indicated that the surface marker CD30, along with other surface markers, 
can greatly enhance the distinguishing and identification of fully reprogrammed cells 
[70]. While the expression of surface markers provides a useful metric for measuring 
reprogramming progress and assessing pluripotency, the transcriptional heterogeneity 
and potential of these cells to generate fully reprogrammed iPSCs remain unknown. 
Another way to measure the progression toward fully reprogrammed iPSCs is by 
assessing the expression of transcriptional markers. The genome-wide expression of 
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somatic cells during reprogramming showed downregulation of fibroblast markers, 
downregulation of mesenchymal-related genes, activation of chromatin modifiers, 
activation of epithelial-related genes, and activation of pluripotency-related genes 
[5,38,71]. For example, in early reprogramming, the transcriptional markers LOX and 
LUM (fibroblast markers) and SNAI1 and TGFBR2 (mesenchymal markers), are 
downregulated, whereas KAT7 (chromatin modifiers), and CDH2 (epithelial markers) 
are upregulated. The expression of ZFP42 and SALL4 (pluripotency markers) is 
activated during the intermediate phase of reprogramming and the expression of late 
pluripotency markers DPPA2 and DPPA4, as well as the robust expression of SOX2, 
may define the late, stabilization, or maturation phases of reprogramming [72].  
However, due to transcriptional heterogeneity and the expression of predictive 
markers in both fully reprogrammed and partially reprogrammed iPSCs, transcriptional 
markers alone cannot distinguish fully reprogrammed iPSCs from partially 
reprogrammed iPSCs. As a result, only the teratoma assay can accurately distinguish 
fully reprogrammed iPSCs from partially reprogrammed iPSCs. 
1.4 Currently proposed reprogramming models 
After demonstrating that reprogramming induces pluripotent stem cells using four 
defined factors, a wave of different models has been proposed to describe the kinetics 
of reprogramming. In principle, somatic reprogramming can be explained by two 
mechanisms: (1) a stochastic mode, in which generation of iPSCs appears to be in 
variable latency as a result of random acquisition of pluripotency in reprogramming cells 
[3,15,73], or (2) a deterministic mode, in which reprogramming cells undergo a defined 
order of reprogramming events with fixed latency [5,68,74]. The stochastic model is 
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strongly supported by numerical modeling [69,71], whereas the deterministic 
reprogramming model is supported by the transcriptional kinetics observed upon 
elimination of Mbd3 [75,76].  
Recently, analysis of single reprogramming cells and intermediate subpopulations 
[72] has indicated that the stochastic and deterministic changes in gene expression are 
associated with distinct phases of the reprogramming process [57,77]. During early 
reprogramming, changes in gene expression are largely stochastic, whereas the later 
stages are marked by robust expression of endogenous SOX2 [72]b with a deterministic 
order of gene expression. In addition, the roadmap defined by genome-wide 
transcriptional analysis reveals that there are two major waves of gene activity at the 
early and late stages of reprogramming, with the stochastic phase being observed 
between these stages. The deterministic reprogramming mode appears to agree with 
the stabilization phase defined by Wrana, further supporting the notion of the 
reprogramming process as being mostly stochastic, followed by a deterministic phase. 
1.5 Scope of this thesis 
Current models suggest that reprogramming to pluripotency occurs in two phases: 
an extended stochastic phase followed by a rapid deterministic phase. The stochastic 
phase is believed to be a major rate-limiting step in the successful generation of 
induced pluripotent stem cells. Furthermore, a detailed mechanistic understanding of 
the stochastic reprogramming phase continues to prove elusive despite considerable 
effort.  
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The results presented here provide a precise understanding of gene expression 
dynamics and mathematical modeling during the stochastic reprogramming phase. 
Moreover, these results will enable the measurement and mechanistic dissection of 
treatments that improve the efficiency of somatic reprogramming, along with dissecting 
the importance of the initial genetic status of starting cell types. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  12 
Chapter 2 Single cell transcript analysis of monocistronic OSKM factors somatic 
reprogramming cells 
 
2.1 Introduction 
 
Methods of reprograming somatic cells to a pluripotent state (iPSC) have 
enabled the direct modeling of human disease and ultimately promise to revolutionize 
regenerative medicine [78,79]. While iPSCs can be consistently generated through viral 
infection with the Yamanaka Factors OCT4, SOX2, KLF4, and c-MYC (OSKM) [1], 
infected cells rapidly become heterogeneous with significant differences in 
transcriptional and epigenetic profiles, as well as developmental potential [80–84]. This 
heterogeneity, the low efficiency of iPSC generation (0.1-0.01%) and the fact that many 
iPSC lines display karyotypic and phenotypic abnormalities [85–87] has hindered the 
production of iPSCs that can be used safely and reliably in a clinical setting.  
Several reprogramming studies using  ChIP-seq and RNA-Seq experiments have 
revealed ensemble gene expression and epigenetic changes that occur during 
reprogramming by OSKM, and have greatly enhanced our understanding of the process 
[79,88,53,45,55]. These studies require the use of populations of cells comprised of 
heterogeneous mixtures undergoing reprogramming (0.01-0.1% of which will become 
iPSC) or stable, partially reprogrammed, self-renewing lines arrested in a partially 
reprogrammed state, unlikely to ever become iPSCs without additional manipulation 
[81–84]. Because these techniques rely on either the ensemble properties of mixed 
populations, or upon the analysis of cell lines arrested at partially reprogrammed states 
that may not be representative of normal intermediate steps in a functional 
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reprogramming process, they have limited ability to reveal the changes that appear to 
be essential to successful reprogramming. 
Furthermore, single-cell imaging studies provide a powerful complement to 
ensemble, population level analyses. Live imaging studies have identified a number of 
key morphological and cell cycle related changes that occur during reprogramming to 
iPSC [52,56]. These observations suggest that an ordered set of phenotypic changes 
precede acquisition of the fully pluripotent state [53]. However, these studies are 
necessarily limited in their molecular-genetic resolution, and they provide little insight to 
the transcriptional changes accompanying key morphological and developmental 
transitions in the reprogramming process. This chapter is a transcript of the manuscript 
published on this work in 2014, in Plos One. 
2.1.1 Single cell analysis of reprogramming reveal that reprogramming is proceed in 
two major phases 
 
Recent studies of a single-cell transcriptional analysis of reprogramming of 
mouse fibroblasts by OSKM revealed that reprogramming proceeds in two major 
phases: an early stochastic phase followed by a rapid “hierarchical” phase [57]. While 
the latter phase appears deterministic and is characterized by the coordinated 
expression of pluripotency genes in an ordered fashion, the early phase exhibits 
apparently random gene expression patterns that persist through the majority of the 
process [57,77]. This conclusion is further supported by two key pieces of evidence 
from other studies, which specified a transgenic OSKM activity is required for the 
majority of the reprogramming process, indicating that most of this process is not 
governed by the concerted action of the endogenous pluripotency gene regulatory 
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network (GRN) [52,69,15], and a mechanistically undescribed period of variable 
‘latency’ of cells in the stochastic phase results in significant temporal variability in the 
appearance of fully reprogrammed iPSC colonies [3]. 
2.1.2 Chromatin remodeling during early stochastic phase of reprogramming 
 
Several studies have attributed the protracted stochastic phase to the 
requirement for extensive chromatin remodeling during reprogramming [89,90]. These 
changes involve the complex coordination of factors to deposit and remove histone 
modifications and DNA methylation at specific loci to achieve a pluripotent epigenetic 
state. The need to reset the epigenetic landscape appears to delay the coordinated 
activation of the pluripotency GRN and is likely to be a major barrier to rapid and 
efficient reprogramming. Indeed, it has been shown that OSKM binding in the early 
stages of reprogramming is greatly impeded by the presence of repressive chromatin, 
and initial binding is largely restricted to existing open chromatin domains 
[79,45,55,91,54]. Consequent remodeling of somatic cell chromatin clearly occurs, but 
the order and mechanism of remodeling events during the stochastic phase is not fully 
understood.  
Many studies have suggested that the stochastic phase is a major rate-limiting 
step in the reprogramming process, but provide little mechanistic insight into the 
molecular underpinnings of these events. In addition, it has not yet been determined 
how these findings translate to the reprogramming of human cells, which will be 
required prior to clinical application of iPSCs.  In order to alleviate these issues during 
reprogramming, generating accurate map of gene expression dynamics during the 
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stochastic phase are essential and this map can provide a framework for the molecular 
dissection of these rate-limiting events in reprogramming. 
In this study, we perform single-cell transcript analysis of MRC-5 human lung 
fibroblasts undergoing reprogramming by OSKM and demonstrate that changes in gene 
expression in the stochastic phase of reprogramming are not simply gradual and 
random; rather, genes are activated and inactivated at specific points during the 
progression from fibroblast to iPSC. Coupling single-cell transcript profiling with 
mathematical modeling, we illustrate that the gradual acquisition of pluripotency gene 
expression during reprogramming occurs as an ordered, probabilistic, gene-specific 
process that shows no signatures of interdependence between genes. 
Furthermore, we generate reprogramming map using single cell transcript 
profiling, which provides a robust model that can be used to dissect the precise 
mechanisms and chromatin modifications that limit the rate and efficiency of conversion 
of somatic cells to iPSC. Our results and finding will lays the foundation for the precise 
measurement and mechanistic dissection of this critical rate-limiting step in 
reprogramming. 
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2.2 Results 
2.2.1 Reprogramming Experimental Design 
 
In order to dissect the reprogramming mechanism, first we combine qualitatively 
and quantitatively robust single-cell transcript profiling [92] with FACS to measure the 
progression of individual MRC-5 human fetal lung fibroblasts through the 
reprogramming process. To make our results as broadly relevant as possible, we used 
viral delivery of the OSKM transgene cocktail, the most widespread method applied to 
human cell reprogramming [93,94]. At select time points after transduction, cells were 
dissociated, stained, analyzed and collected by FACS. FACS markers used in this study 
include GFP (virus derived), αSSEA4, αTRA-1-60, and αCDH1 (see Materials and 
Methods). These markers were essential and allowed for enrichment of the rare cells 
exhibiting hallmarks of productive reprogramming. For example, SSEA4 and TRA-1-60 
routinely provide ~30 and 3,000 fold enrichment, respectively (data not shown). While 
very few SSEA4+ cells are likely to become true iPSCs, they provide a measurement of 
cells that have begun to exit the fibroblast in response to OSKM transduction. In 
contrast, isolation of TRA-1-60+ cells later in reprogramming (Day 14) is likely to yield a 
large number of cells destined to become iPSC. In fact, >90% of these cells remain 
TRA-1-60+ after sorting and subsequent culture and this stability of the TRA-1-60+ 
phenotype has been shown to be a major determinant for the potential of cells to 
become iPSC [95]. Single cells with defined FACS phenotypes were collected into cell 
lysis buffer and subject to single-cell RT-qPCR as previously described [92] (Figure 1A). 
Throughout the course of this study we isolated and pre-screened 576 cells in total, 
using 172 cells that passed quality control for our final analysis (see Materials and 
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Methods and Table S3). This includes many partially reprogrammed cells, as well as an 
un-transduced set of MRC-5 fibroblasts and H9 human embryonic stem cells (H9-
hESC), which represent the beginning and end states of the process, respectively. 
 
Figure 1 A: Schematic representation of the pipeline used to isolate and analyze single cells 
undergoing OSKM-mediated reprogramming. A) Cells were infected with OSKM (MOI = 5) and cultured 
for 4, 8 or 14 days prior to harvest. Cells were then singularized and stained with SSEA4 and TRA-1-60 
antibodies and subjected to FACS. SSEA4+/TRA-1-60- (SSEA) and SSEA4+/TRA-1-60+ (TRA-1-60) single cells 
were sorted directly into lysis buffer in 96-well plates followed by RT and linear pre-amplification. 
Amplified cDNA samples were used for Taqman qPCR analysis of 48 genes on an Applied Biosystems 
7900HT real time machine and data analysis was performed in JMP. 
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2.2.2 Measuring progression towards pluripotency 
 
In order to measure progression towards to pluripotency, and away from the 
initial fibroblast state, we assembled a 48-gene qPCR (Table S1) panel including genes 
expressed in fibroblasts [56,96,6], a large number of genes involved in the maintenance 
of pluripotency (including various chromatin modifiers) [88,97–99] and genes previously 
suggested to be intermediate markers of the reprogramming process [68,38] (Figure 
1B). Initial visualization of the full dataset by unsupervised hierarchical clustering 
reveals that our FACS sorting strategy, and qPCR marker panel, isolates statistically 
separable populations that capture a range of transcriptional phenotypes between the 
fibroblast and pluripotent states (Figure 1C). These full dataset are further analyzed by 
series of statistical analyses to describe probable trajectories followed by OSKM-
infected cells; measure the progress of cellular transcriptional profiles toward a 
pluripotent transcriptional phenotype; and determine the order of gene activation during 
the reprogramming process. 
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Figure 1 B-C: B) Table of the 48 gene panel used for qPCR analysis, categorized as fibroblast-associated, 
pluripotency-associated, intermediate marker or chromatin modifier gene. C) Unsupervised hierarchical 
clustering analysis illustrating the effective isolation of single cells by FACS for SSEA4 and TRA-1-60 
surface markers. While some overlap is observed between the two populations, they are largely 
transcriptionally separable. GFP+-only and CDH1+ populations have been excluded for illustrative 
purposes.  
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2.2.3 Mapping the trajectory of monocistronic OSKM-infected cell throughout 
reprogramming 
 
A series statistical analysis of transcriptional profile of intermediate 
reprogramming cell reveals that OSKM infected cells exit the fibroblast state along two 
distinct trajectories: a productive trajectory toward increasingly ESC-like expression 
profiles or an alternative trajectory leading away from both the fibroblast and ESC state. 
These two pathways are distinguished by the coordinated expression of a small group 
of chromatin modifiers in the productive trajectory, which marks a key early step 
towards successful reprogramming and the rapid upregulation of chromatin modification 
genes is consistent with the need for extensive chromatin remodeling prior to 
establishment of the endogenous pluripotent GRN [79,100,73]. 
2.2.3.1 Principle component analysis 
 
As a first step in visualizing our single cell transcription dataset, we used principal 
components analysis (PCA) to assess the complexity and major sources of variation in 
gene expression between all cells collected in our study. This analysis uncovers that the 
first two PCA dimensions account for 33.1% of the observed variation, where PC1 
primarily represents a cell’s distance from hESC, and PC2 primarily captures distance 
from fibroblasts (Figure 2A). In addition, these two axes appear to represent distinct 
trajectories followed by cells transduced with OSKM The first is a roughly linear 
productive trajectory between the fibroblast and hESC groups (R2=0.60, Figure 2B) and 
the  second is an orthogonal trajectory leading away from fibroblast but not towards a 
pluripotent phenotype (herein referred to as the alternate trajectory, or ALT). 
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2.2.3.2 Generation of reprogramming progression axis 
 
Since the productive and alternate trajectory are well correlated with the PC1 and 
PC2 dimensions respectively (Figure 2C) and capture much of the variation in our 
dataset, we developed a metric to analyze our data in a 2-dimensional Euclidean space 
that maps each cell’s distance (relative similarity) to the centroids of both the Fibroblast 
and hESC groups. In addition, we construct a Euclidean diagonal between Fibroblast 
and hESC which we term the “reprogramming progression axis”. This axis serves as a 
useful measurement of a given cell’s progression towards pluripotency. 
2.2.3.3 Expression of two reprogramming surface markers; SSEA4 and Tra1-60 
 
Interestingly, when mapping the FACS-sorted phenotypes onto our Euclidean 
similarity graph we noticed that, while SSEA4 and TRA-1-60 appear in the expected 
order (SSEA4+ before TRA-1-60+), the SSEA4+ and SSEA4+/TRA-1-60+ populations 
exhibit considerable transcriptional heterogeneity (Figure 2D). SSEA4 positive cells are 
found in both the productive and alternative trajectories suggesting that, while SSEA4 
may be a reliable marker of exit from the fibroblast state, it does not necessarily indicate 
that cells have moved toward a pluripotent transcriptional phenotype. Even more 
pronounced is the diversity of TRA-1-60 positive cells. The transcriptional phenotype of 
these cells extends from a nearly fibroblast-like profile, to a nearly ESC-like profile. The 
extremely high degree of transcriptional heterogeneity we observe, even within well-
defined and widely utilized FACS profiles, underscores the utility of single cell analysis 
to dissect fine differences in gene expression between partially reprogrammed cells.  
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2.2.3.4 Self Organizing Map 
 
We utilized a Self-Organizing Map (SOM) to identify separable groups along the 
two previously described reprogramming trajectories in both PCA and Euclidean space 
(Figure 2E and F, respectively). Four of these groups (Fib, Early, Late and Pluri) lie 
along the productive trajectory from Fibroblast to ESC and the fifth encompasses cells 
in the alternate trajectory (Alt). It is important to note that while these groups can be 
statistically distinguished from one another, however we do not believe these represent 
discrete stages in the reprogramming process. Further inspection reveals that 
progression along the productive trajectory is characterized by the consolidation of 
chromatin modifier expression, an increased probability of pluripotency gene 
expression, a progressive decrease in the expression of fibroblast markers and 
transient expression or repression of predicted intermediate markers [3,38].  
By comparing transcript expression in these five SOM groups, it shows that 
among the earliest distinctions between the productive and alternate trajectories (Early 
vs Alt) is the induction of chromatin-modifying enzyme expression. While many of these 
genes are expressed at low levels in fibroblasts, they are coordinately up-regulated in 
the “Early” group, and become expressed at uniformly high levels in all cells progressing 
towards pluripotency. In contrast, cells in the alternate trajectory down-regulate or 
eliminate expression of these genes (Figure 2G). In addition, “Alt” cells fail to upregulate 
the expression of early pluripotency genes (Figure 2H) and are found at all of the time 
points examined, suggesting that these cells are unlikely to be on a trajectory that 
ultimately leads to pluripotency, and most likely undergoing either transformation or 
apoptosis [39,40]. 
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Figure 2: Mapping the trajectories of OSKM- infected cells. A) Principle Components Analysis (PCA) 
shows the two trajectories followed by OSKM-infected cells. One productive trajectory leading away 
from the starting fibroblast population (purple oval) and towards the hESC group (teal oval) and a 
second, orthogonal trajectory leading away from both fibroblast and hESC, denoted as the “alternate 
trajectory”.” B) Regression analysis showing the linear nature of the productive trajectory. C) Correlation 
analysis between PC1 and the productive trajectory (C, top panel) and PC2 and the perpendicular 
distance to the productive trajectory. D) Mapping of cell types onto a Euclidean distance graph shows 
the broad range of transcriptional phenotypes observed for SSEA4+ (blue oval) and TRA-1-60+ (pink 
oval) FACS-sorted cells.  Also included are untransfected MRC-5 fibroblasts (purple oval) and pluripotent 
H9 hESC cells (teal oval). Self-Organizing Map (SOM) analysis identifies transcriptionally separable 
groups within our dataset in PCA (E) and Euclidean (F) space. This includes 4 groups along the productive 
trajectory (Fib, Early, Late and Pluri) as well as one group comprised of cells in the alternate trajectory 
(Alt). G) Violin plots comparing expression of chromatin modifier genes between the Alt (red), Fib 
(green) and Early (blue) groups. Gene expression levels are plotted on the y axis, with the width of the 
graph representing the prevalence of cells at a given expression level. H) Bar graph illustration 
differences in pluripotency gene expression between the Alt and Early groups.  
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2.2.3.5 Limitation of this approach 
 
It is important to note that our analysis constructs likely reprogramming 
trajectories by sampling partially reprogrammed cells. This approach is common among 
many efforts to sample dynamic processes and is particularly ubiquitous in attempts to 
dissect the reprogramming process [19,24,39]. We apply the standard parsimonious 
assumption that the shortest path defined by these samples represents the most likely 
trajectories of the process. One caveat of this approach is that we cannot exclude the 
possibility that progression within the observed state-space is non-linear, and may be 
complex and/or cyclical. These possibilities will need to be ruled out with longitudinal 
live cell studies beyond the scope of this work. Another important consequence is that 
while cells clearly take time to traverse the trajectory, we do not expect progress along a 
trajectory to have a linear relationship with time. However, progress may be loosely 
thought of as a surrogate for time but should not be strictly interpreted as such. 
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2.2.4 Mapping coarse changes in gene expression along the productive trajectories 
2.2.4.1 Quantitative gene expression analysis 
 
In order to provide a rough benchmark for other literature examining 
transcriptional changes in ensemble samples of partially reprogramed cells, we 
identified quantitative expression differences between SOM groups along the productive 
trajectory (Figure 3). It is clear from our data that specific changes in gene expression 
occur along different portions of the trajectory, which suggests an underlying order to 
the gradual acquisition of pluripotency gene expression during the reprogramming 
process. However, closer analysis reveals that there does not appear to be tight 
covariance between genes activated along the progression toward pluripotency. 
Representative bubble plots illustrating transcript presence and absence (Figure 3 and 
Figure S2) show that genes being activated during reprogramming exhibit a period of 
heterogeneity in transcript detection prior to being detected in all cells approaching 
pluripotency.  
Furthermore, quantitative analysis of gene expression levels also supports this 
finding (Figure 3, Figure S3). These plots depict gene expression levels on the y-axis, 
overlain with a distribution graph showing the range of expression values within the 
population. A unimodal distribution indicates uniform expression around a mean within 
the population, whereas a bimodal distribution demonstrates a transcriptionally 
heterogeneous population (e.g. high/low) for the gene in question. Nearly all the genes 
in our study exhibit this bimodal behavior at some point along the reprogramming 
trajectory, before achieving a unimodal distribution as they approach the fully 
reprogrammed state, however the point of bimodality varies in a gene-specific manner. 
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These findings demonstrate that the activation or inactivation of gene expression during 
reprogramming proceeds through a probabilistic intermediate step, resulting in 
transcriptionally heterogeneous cell populations, and that the timing of this transition 
occurs with gene specific dynamics.  
2.2.4.2 Comparing Gene expression dynamic between mouse and human 
 
In order to scan for potential differences in reprogramming gene expression 
dynamics between species (mouse and human) we processed our data so that it would 
be roughly comparable to that generated by Polo et al [71]. As in the present study, 
Polo and coworkers used FACS to isolate and measure the transcriptional profiles of a 
large number of partially reprogrammed mouse fibroblasts and clustered genes based 
on their expression dynamics. We compared these clusters to the dynamics of the 
human orthologs [88,97] represented in our dataset (Figure S4). While high-resolution 
comparison was not possible with the publically available mouse data, most genes 
shared between datasets appear to exhibit similar dynamics in the stochastic phase. 
That is, early mouse genes change expression early in the human trajectory, while late 
genes change later in the trajectory. However, despite the coarse limits of resolution in 
this comparison, several genes, including NANOG, LIN28A, POU5F1 and STAT3, 
appear to change at different stages of the reprogramming process in these two 
species. These disparities, while requiring more direct comparison and detailed 
confirmation, are consistent with distinct differences between regulation of the 
pluripotent state in mouse and human cells as well as probable differences in the 
starting chromatin state of loci in mouse and human fibroblasts.  
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Figure 3: (Middle panel) Tukey-Kramer test results showing significant increases or decreases in gene 
expression between the groups identified in the PC-SOM analysis (p>0.05). Genes are ranked in order of 
significance from highest to lowest. Violin and bubble plots (above and below) show qualitative and 
quantitative changes (respectively) in per-cell gene expression for the genes with the greatest change 
between groups. Top panel shows genes whose level and probability of expression undergo an 
“activating” effect during reprogramming, while genes with decreased probability of expression during 
reprogramming are labeled “inactivating” and shown in the bottom panel. 
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2.2.5 Generation of effective reprogramming model by Gaussian Distributions 
 
Our observation that distinct transcriptional differences exist between PC-SOM 
clusters indicates that gene expression changes during the stochastic phase of 
reprogramming appears to occur in an ordered fashion. However, the coarse grained 
nature of this differential analysis between statistically identifiable, but not necessarily 
biologically relevant groups provides little insight to the exact nature of the order of gene 
expression dynamics during the stochastic phase. In particular, we wanted to address 
two specific questions: 1) Is the acquisition of pluripotency gene expression random and 
gradual, with all genes approaching a pluripotent profile at a uniform rate over the 
course of the process?; and 2) Is there sub-structure within the patterns of gene 
activation that would suggest the activation of modules within the pluripotency GRN? 
We addressed these questions by differentiating between null and alternative 
hypotheses (in the form of distribution models) predicting gene expression frequencies 
along the reprogramming trajectory from MRC-5 to H9-ESC and comparing these to 
what we observe in our experiments. 
2.2.5.1 Addressing two hypothesis by two models 
 
In order to formally address the first question, we modeled random gradual 
change in gene expression by assigning each fibroblast and pluripotency marker a 
uniform rate (probability) of change along the trajectory from MRC-5 to H9-ESC that 
would result in predicted gene expression frequencies that match the observed 
frequencies at the start (MRC-5) and end (H9-ESC) of the process [71]. In contrast, our 
alternative hypothesis was that genes change expression at specific stages of the 
process; in other words, gene expression during the stochastic phase is ordered. This 
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alternative scenario was modeled by fitting Gaussian probability distributions to each 
gene such that the probability distribution was centered at the point of greatest change 
in gene expression frequency along the reprogramming trajectory.  
In order to model the behavior of transient genes, and to help calibrate 
differences between goodness of fit between models, we also built more complex 
models with two probability distributions, which allowed us to model genes that change 
expression at two points in the process. Changes in gene expression frequency 
predicted by our null model are linear, while the alternative model with one probability 
distribution predicts sigmoidal changes and the two distribution model allows for more 
complex dynamics of change in gene expression frequency, such as transient activation 
or inactivation. The goodness of fit of each model to our observed data was then 
measured for each gene in both PCA and Euclidean space using an F-test statistic. 
Because goodness of fit typically scales with the number of parameters in a model, the 
Gaussian models were penalized for added parameters using a corrected Akaike 
Information Criterion (AIC, see Materials and Methods). The results of these tests can 
be found in (Figure 4A-D and Table S2). 
As demonstrated in Figure 4B, the vast majority of genes reject the null 
hypothesis (F-statistic > F-Critical) in favor of a Gaussian model. Note that many genes 
that reject the null hypothesis do so very strongly, while the few genes that better fit 
linear dynamics do so only marginally (Figure 4C). In addition, most genes that do not 
reject the uniform model exhibit little or no change over the course of reprogramming or 
have noisy expression profiles. Both of these observations suggest that most gene 
expression changes occurring during the stochastic phase are not simply gradual 
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acquisition of an ESC-like expression frequency, rather they turn on and off at specific 
points in the process. 
2.2.5.2 Comparisons of models 
 
To further assess the confidence with which random change (uniform probability 
distribution) in gene expression during the stochastic phase can be rejected by our 
models (Gaussian probability distribution) is to compare the explanatory power of each 
model, as adjusted for the additional parameters required in each more progressively 
complex scenario. Figure 4D shows that while one normal distribution significantly 
improves AIC (lower is better), two normal (or even three normal - data not shown) do 
not add much explanatory power. One exception is for genes that exhibit transient 
expression changes, the fits for which are shown in Figure S6.  
For this reason, we suggest that gene expression dynamics during the stochastic 
phase are best described as events occurring at specific points in the process, where 
most gene’s expression dynamics are well described by a single normal probability 
distribution centered at the point of maximal rate of change. Genes that change at very 
specific points in the process have very tight probability distributions, while genes with 
less precise dynamics display broader probability distributions (approaching the uniform 
distribution of our null model).  
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Figure 4: Rejection of a uniform model and justification of modeling using Gaussian distributions. (A) 
Predicted outcomes of gene expression probabilities associated with uniform (left panel) or Gaussian 
(right panel). Uniform and Gaussian probability distributions (dashed line) give rise to cumulative 
probabilities (solid line) that describe the population of cells at a given point in time. A Uniform 
probability results in the gradual activation / inactivation of a gene throughout the process, while 
Gaussian distributions suggest a bias in expression change towards a particular point in the process. (B) 
Pie charts showing the relative number of genes that accept or reject the Uniform (left panel) or 
Gaussian model (right panel) as determined using an F-statistic test. The strength with which these 
genes accept or reject each model is shown in (C).  (D) Comparison of AICC value for all genes between 
the Uniform model and a Gaussian model using one or two normal distributions. While considerable 
improvement is observed for the Gaussian vs Uniform model, the addition of a second normal 
distribution does not dramatically improve model fit. 
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2.2.6 Gene expression dynamics during monocistronic OSKM somatic reprogramming 
 
In order to compare dynamics between genes, we modeled each gene in our 
study using single Gaussian probability distributions as described above. All model fits 
are illustrated in the Figures S5. One example fit is illustrated for CDH1 in Figure 5A. In 
this figure the black dots represent measured expression frequencies of CDH1 in sliding 
windows along the inferred reprograming trajectory. The red curve shows gene 
expression dynamics modeled as a Gaussian probability distribution fit to the 
experimental data and the blue line illustrates expression frequencies predicted by that 
probability curve.  
When the dynamics of several genes are compared in one graph (Figure 5B-E) it 
is readily evident that genes are activated or inactivated at different points during the 
reprogramming process, genes have specific stringencies in their activation dynamics 
(some genes change at fairly specific stages, while others change over almost the 
entire course of the process), and there is considerable overlap in the expression 
probabilities of individual genes. Most genes are activated or repressed with diffuse 
dynamics, while several (NANOG, CDH1, ZFP42, ZIC3 and OTX2) change at more 
specific stages of the reprogramming process. The diffuse dynamics and broad 
windows of activation observed for most pluripotency markers is consistent with the 
longitudinal observation that the expression of the surface antigens SSEA4 and TRA-1-
60 in iPSC colonies are not strongly predictive of successful reprogramming events 
[68,69].   
Putting together, this data strongly supports the hypothesis that rather than being 
a strictly ordered or strictly random process, the stochastic phase of reprogramming is 
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an ordered probabilistic process. Seen in this light, prior ordered and random models 
can be coherently united [72][101][77]. 
 
 
 
Figure 5: (A) Goodness of fit of a Gaussian model using activation of the CDH1 gene as an example. 
Gaussian distributions are represented as box and whisker plots for activating (B) and inactivating (C) 
genes. Yellow boxes and blue whiskers represent the 50% and 95% confidence intervals of the normal 
curve respectively, with the means shown as black lines. Cumulative distributions derived from the 
Gaussian model are overlaid for genes that are activated (D) or inactivated (E) during the course of 
reprogramming. 
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2.2.7 Pluripotency Gene Regulatory Network during the Stochastic Phase of Reprogramming 
 
Having observed ordered dynamics in the stochastic phase, we sought to 
determine if there was any indication that this order might arise from the partial 
activation of the endogenous pluripotency GRN. Current models suggest that partially 
reprogrammed cells enter a late, rapid deterministic phase that is controlled by 
activation of the endogenous pluripotency GRN and may be marked (in mouse cells) by 
the activation of the endogenous Sox2 locus [20,46]. Alternatively, order could emerge 
gradually or fractionally during the stochastic phase. A hallmark of concerted gene 
regulation as exerted by a GRN, is strong correlation (or anti-correlation) between gene 
expression patterns [57,77,71].  
Our model provides a powerful way to detect correlated gene expression that lies 
above the background correlations inherent during reprogramming (i.e. pluripotency 
markers all become expressed in fully reprogrammed cells). Based on our model, we 
generate two hypotheses that can explain gene expression correlation during stochastic 
phase of reprogramming. First, our null hypothesis is that during the stochastic phase 
there is no dependency between genes and that all correlation between gene 
expression in individual cells results simply from the increase in frequency of 
pluripotency markers as cells approach an ESC-like transcriptional profile. Second, our 
alternative hypothesis is that some pluripotency genes may be co-regulated (or cross-
regulate) during the stochastic phase and would thus display higher than background 
levels of co-expression (as measured by correlation). 
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  To test these hypotheses we used the probability profiles of each gene to 
generate a simulated data set in which gene expression is determined only by the 
probability profile of each gene, with no dependencies between genes. The resulting 
dataset accurately recapitulates the individual dynamics of each gene in our dataset, 
and provides pairwise correlation values that are solely dependent upon the 
convergence of all pluripotency markers on uniform expression in ESC. We then 
compared pairwise correlations between genes in this background data set with the real 
correlations observed in our single-cell transcript data (Figure 6).  
Interestingly, the only correlations we find rise above background expectations 
occur between a set of chromatin regulators that distinguish between entry into the 
productive trajectory and entry into the alternative trajectory (Figure 6). This coordinated 
activity is likely the result of activation of the c-MYC GRN, which is known to be 
activated upon OSKM induction, and is largely limited to genes with a permissive 
chromatin state in fibroblasts as is the case for many chromatin modifier genes 
[102,103] (Figure 6, inset).  
In contrast, none of the correlations between members of the pluripotency GRN 
rise above background expectations, despite their overall increase in expression 
frequency as cells approach an ESC-like expression profile. We therefore accept the 
null hypothesis: that despite the ordered activation of genes in the pluripotency GRN 
during the reprogramming process, there is no evidence for gradual or modular 
activation of the pluripotency GRN during the stochastic phase of reprogramming.  
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The numbers of genes we analyze in our study somewhat limits the power of this 
analysis, and a more comprehensive single-cell study measuring many more genes 
might uncover obligate relationships between genes that are not apparent in our core 
pluripotency GRN gene set. However, an important outcome that follows from this result 
is that the dynamics of gene activation during the stochastic phase appear to depend 
only upon the local properties of each gene, rather than the sequential activation of 
precursors in the GRN.  
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Figure 6: Cells undergoing reprogramming do not show hallmarks of activation of the pluripotency GRN. 
Heat map shows background-corrected Pearson’s correlation coefficients for all genes in our dataset, 
excluding NR0B1 and REST (due low detection frequency). Significant correlations (red dots) are 
primarily observed for chromatin genes, while the majority of pluripotency genes show no significant 
correlations (blue dotes).  A small group of pluripotency genes with significant correlations exhibit an 
open chromatin state in the starting cell type indicated by H3K4me3 promoter methylation and DNase 
hypersensitivity (Inset). 
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2.2.8 Reprogramming model 
 
  We generate a model (Figure 7) that describing the reprogramming trajectories, 
transcriptional phenotypes and its dynamics during somatic cell reprogramming using 
individual OSKM factors. Our model indicate that cells that undergoing reprogramming, 
located either productive trajectory leading towards pluripotency and an alternate 
trajectory away from fibroblast but not towards a hESC phenotypes. The productive 
trajectory is characterized by the expression of both SSEA4 and TRA1-60 surface 
markers, and in general involves the down regulation of fibroblast markers, cell cycle 
associated genes, and simultaneous gene that involve in chromatin modification and 
pluripotency genes are up regulated. 
 Furthermore, coupling our finding with other reprogramming model and 
literatures, we observe early wave of gene induction involving chromatin modified 
enzyme and other loci with an open chromatin state that is probably the results of KLF4 
and cMYC activity at these promoters, and this initial wave is tailed by probabilistic 
independent gene expression period, which describe in our model. This probabilistic 
phase of gene activation will ultimately lead to yet unidentified events that allow 
transition into deterministic phase and acquisition of pluripotency GRN. 
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Figure 7: Combined models describing the trajectories and transcriptional phenotypes observed during 
somatic cell reprogramming. (Top panel) Two trajectories are observed for cells undergoing 
reprogramming by OSKM, a productive trajectory leading towards pluripotency and an alternate 
trajectory away from fibroblast but not towards a hESC phenotype. The productive trajectory is 
characterized by the expression of the surface markers SSEA4 early and TRA-1-60 late in the process, 
and in general, involves the down-regulation of fibroblast and cell cycle-associated genes and 
simultaneous up-regulation of chromatin modifier and pluripotency genes. Putting our results in the 
context of the current literature, we observe an early wave of gene induction involving chromatin 
modifying enzymes and other loci with an open chromatin state that is likely the result of cMYC and 
KLF4 activity at these promoters. This initial wave is followed by a period of independent probabilistic 
gene expression, which we have model using a series independent Gaussian distributions. This 
probabilistic phase of pluripotency gene activation will eventually lead to an as yet unknown event that 
allows transition into the deterministic phase and the subsequent acquisition of pluripotency.  
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2.3 Discussion 
 
In this study we present a rigorous single cell analysis of reprogramming in 
human cells and show that the stochastic phase of reprogramming of human fibroblasts 
by OSKM is an ordered probabilistic process which can be simply modeled using 
independent Gaussian distributions. An advantage of our approach lies in the fact that it 
makes no a priori assumptions about the progression of cells toward pluripotency, 
based on time or surface marker expression, both of which are poor indicators of 
reprogramming progress.  
In addition, the simplicity of our model and its exceptional fit to our observed 
expression dynamics provide a tractable framework for further dissecting the rate-
limiting aspects of reprogramming. The results of this work also unify existing ordered 
and random models of the stochastic phase of reprogramming [68,52,56,57,15,3] and 
are consistent with observations from both population level and single cell studies of 
gene expression changes during reprogramming [68,38,72]. The ordered nature of the 
stochastic phase is readily apparent in the distinct, gene-specific expression dynamics 
we observe during reprogramming, while the probabilistic nature of the process is 
evident in broad gene-specific expression dynamics over large portions of the 
reprogramming trajectory (Figure 5 and Figure 7), and the apparently independent 
control of gene expression dynamics during the stochastic phase (Figure 6). These 
findings are consistent with a recent study by Tanabe et al. [95] that suggests the TRA-
1-60+ phenotype is unstable and transcriptionally heterogeneous and that stabilization 
of the TRA-1-60+ population is a critical rate limiting step in reprogramming.  
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2.3.1 Transcriptional Heterogeneity expression 
 
We note that variations in the cell cycle could contribute to the transcriptional 
heterogeneity of a subset of genes in our dataset. However recent studies in hESC 
have shown that the transcription of genes associated with pluripotency does not 
fluctuate during the cell cycle [104], suggesting that cell cycle status is unlikely to have a 
major impact on our analysis of the activation of the pluripotency GRN. In addition, the 
persistence of cyclin transcripts throughout the cell cycle and their considerable post-
transcriptional regulation in ESC’s [105], precludes strong inference of cell cycle status 
from transcriptional measurement of a single cell-cycle regulator.  
Another possible source of transcriptional heterogeneity between partially 
reprogrammed cells in our cultures could be the delivery of O, S, K, and M on individual 
vectors (as is standard in widely utilized human reprogramming protocols). However the 
broad agreement of expression dynamics over the course of reprogramming between 
our results using individual viral delivery, and those reported by Polo et al using an 
inducible, polycistronic construct in a clonal cell line, suggests that viral heterogeneity 
does not fundamentally affect the order of gene expression dynamics, or the shape of 
the trajectory of cells undergoing the reprogramming process.  
Furthermore, the initial description of the highly heterogeneous nature of the 
stochastic phase by Buganim et al was also derived from data using clonal cells 
expressing OSKM from an inducible polycistronic OSKM construct. Thus, the stochastic 
nature of this phase does not appear to be a direct consequence of OSKM 
heterogeneity. However, these results do not rule out the possibility that each of the 
OSKM factors have distinct roles in various stages of the reprogramming process, nor 
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that heterogeneity in OSKM content will be observed across the partially reprogrammed 
population of cells. Indeed, understanding the role of each factor in the reprogramming 
process and the critical window for the action of each represents an important goal of 
future work.  
2.3.2 Activation of genes during reprogramming 
 
One consequence of the independent activation of genes during reprogramming 
is that an extremely wide variety of cell states are present during the reprogramming 
process, which gives the overt appearance of disorder. Thus, while any given partially 
reprogrammed cell’s gene expression pattern may appear to be random, the 
probabilities of expression of individual genes are clearly biased towards specific points 
along the reprogramming trajectory. One implication of these findings is that any single 
marker is unlikely to be effective at determining the extent to which a given cell has 
been reprogrammed [68,5].  
2.3.3 Local chromatin architecture of the pluripotency gene attribute to reprograming 
efficiency 
 
A likely explanation for the apparent lack of deterministic behavior during the 
stochastic phase may be the existence of as yet unidentified, gene-specific factors that 
restrict the rate of transcription activation by OSKM. One compelling candidate for these 
factors is the local chromatin architecture of the pluripotency genes in the starting 
somatic cell type. Indeed, epigenetic remodeling was implicated as a major rate limiting 
step in even the earliest days of somatic cell reprogramming using nuclear transfer 
[89,90] and is almost certainly one of the most important probabilistic events limiting the 
rate and efficiency of reprogramming. Many reports have experimentally validated this 
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hypothesis by demonstrating that global chromatin reorganization is critical for 
successful reprogramming [79,45,55,54]. Because many of the required changes in 
chromatin state appear to occur in a slow and probabilistic fashion [106–108] it is likely 
that these changes limit the rate at which exogenous OSKM can activate the 
endogenous pluripotency GRN thus limiting the efficiency and speed of reprogramming 
and endowing the majority of the process with stochastic dynamics.  
2.3.4 Successful Reprogramming required enhance expression of chromatin modifiers  
 
Our finding, that enhanced expression of chromatin modifiers is a hallmark of 
entry into productive reprogramming complements several studies demonstrating that 
successful reprogramming requires the gradual erosion of epigenetic barriers to 
activation of the pluripotency GRN by OSKM [79,91,54,109,4]. This event is likely 
governed by the activity of c-MYC, which together with KLF4, acts early in 
reprogramming to activate loci with permissive chromatin states, including many 
chromatin modifier loci in fibroblasts [45,91]. In addition, many treatments known to 
enable chromatin remodeling have been shown to enhance the rate and/or efficiency of 
the reprogramming process [109,39,110,40], while, conversely, knocking down factors 
required for such epigenetic changes can inhibit or prevent successful reprogramming 
[109,39,40,111–113]. However, with the exception of some very early events [45,91] the 
order and precise identity of chromatin modifications required for successful 
reprogramming is not yet well known.  
By precisely describing and modeling gene expression dynamics during the 
stochastic phase the present study provides a quantitative framework for dissecting 
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these key rate limiting steps and will enable the mechanistic dissection of interventions 
known to accelerate or enhance the efficiency of the reprogramming process. 
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Chapter 3 Polycistronic delivery of OSKM reprogramming factors improves 
reprogramming efficiency compared to monocistronic reprogramming  
3.1 Introduction 
 
Many efforts to illuminate the molecular underpinnings of reprogramming have 
been complicated by the inefficiency and temporal asynchrony of the process. Only 
0.01-1% of cells reach the pluripotent state and they do so at different rates over the 
course of a 3- to 4-week period. As a result, the majority of studies conducted to date 
that rely on bulk measurement of heterogeneous populations of cells are inherently 
biased towards analyzing unsuccessful reprogramming events. Thus, measurement of 
transcriptional or other events leading to pluripotency may be obscured. To overcome 
this limitation of bulk analysis our group and others have used single cell analysis and 
mathematical modeling to deconstruct the transcriptional and protein-level changes 
occurring in cells undergoing reprogramming [53,72,114,115]. 
By profiling individual cells en route to pluripotency, we are better able to assess 
how the pluripotency gene regulatory network (GRN) becomes activated in response to 
the OSKM factors. Specifically, it allows us to determine whether this activation 
happens as a series of concerted deterministic events or occurs gradually over the 
duration of the process. Equally important is the ability to measure what appear to be 
unsuccessful reprogramming events leading to trajectories other than pluripotency. 
Identifying common features in divergent cells can reveal events that prevent cells from 
becoming iPSCs. 
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An earlier work proposed a model wherein acquisition of pluripotency is primarily 
limited by an early probabilistic or stochastic phase. During this phase, genes 
associated with pluripotency activate independently and lack the coordinated 
expression that is characteristic of a stable pluripotent state [56,3,72,101]. This period 
can persist for a variable length of time, after which cells that have made the requisite 
epigenetic and transcriptional changes activate the pluripotency gene regulatory 
network (GRN) and are stabilized in the iPSC state [77,72,75]. The stabilization of this 
network requires precisely controlled levels of OSKM expression [91,116]. Premature 
inactivation of exogenous OSKM fails to generate iPSCs [15,117]. Conversely, failure to 
inactivate the OSKM cassette forces cells into an alternate ESC-like state, distinct from 
iPSCs [118]. Given the relationship between factor stoichiometry and efficiency, it is 
important to assess how variations in the reprogramming method impact the acquisition 
of pluripotency. 
Comparing monocistronic and polycistronic viral delivery of the four factors is of 
particular interest, as this remains the most widely utilized reprogramming strategy in 
the human system [64,1]. Monocistronic delivery enables flexibility in the stoichiometry 
of factor delivery due to random integration of the individual constructs. However, many 
cells receive combinations of factors that are suboptimal for reprogramming or ones that 
may cause cells to take a different trajectory to the pluripotent state [116,119]. By 
contrast, polycistronic delivery fixes the ratio of factor delivery at 1:1:1:1, a ratio that 
may not be optimal for successful reprogramming, but one that guarantees that all 
transfected cells will carry a full complement of the reprogramming factors. In separate 
studies, it has been demonstrated that mono- and polycistronic systems reprogram cells 
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at different efficiencies in mice (0.01% and 0.5%, respectively), and in humans (0.2% 
and 1.5%, respectively) [1,94,112,48,120]. However, no direct comparison of these 
methods has yet been performed. Furthermore, species-specific differences in the 
molecular events leading to pluripotency exist between mice and humans [30], further 
complicating the comparison of these two techniques and underscoring the importance 
of studying reprogramming in human cells for clinical purposes.  
In this chapter, we use single-cell transcript analysis to compare the 
transcriptional dynamics underlying the acquisition of pluripotency in monocistronic and 
polycistronic OSKM systems. We demonstrate that polycistronic viral delivery produced 
significantly higher reprogramming efficiencies than monocistronic delivery, and that this 
effect is caused in part by premature inactivation of the individual O, S, K, or M vectors 
in the monocistronic method. In addition, we show that the activation of key pluripotency 
loci, such as NANOG, OCT4, LIN28, and DNMT3B, occurred earlier in the polycistronic 
condition, and that these cells progressed more uniformly toward pluripotency. 
 
 
 
 
 
 
 
  48 
 
3.2 Results 
 3.2.1 Monocistronic and polycistronic reprogramming efficiency 
 
To assess the reprogramming efficiency of the monocistronic (Mono) and 
polycistronic (Poly) reprogramming methods, we used FACS to analyze the percentage 
of SSEA4 single-positive (S+T-) and SSEA4/TRA-1-60 double-positive (S+T+) cells, 
markers associated with early and late reprogramming, respectively [68,69,5]. We 
observed a significant enrichment of S+T- cells in the Poly condition compared to the 
Mono condition, which increased from a 2-fold difference at D4 to a greater than 8-fold 
difference at D14. This trend was seen in TRA-1-60+ cells as well, where Poly exhibits 
an approximately 15-fold increase at both time points analyzed (Figure 8C).  
To determine whether the difference in SSEA4 and TRA-1-60 expression 
between the conditions was correlated with reprogramming efficiency, we stained and 
counted AP+ colonies at D21 and D28. Poly cells had 10-fold more AP+ colonies than 
Mono cells at D21, and this increase was even more pronounced at D28, the point at 
which colonies are typically selected to establish iPSCs (Figure 8D). This corresponds 
to an efficiency of approximately 5% and 0.5% for Poly and Mono cells, respectively. 
This is consistent with previous reports showing a 10-fold increase in reprogramming 
efficiency between the two conditions, albeit in separate studies [64,1,121]. In our 
experience, Mono colonies tended to be broad and covered more area than Poly 
colonies, which were small and punctate. Example colonies are shown in Figure 8B. To 
ensure that this difference in morphology did not skew our colony-counting results, we 
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also measured the total area of the plate that was covered by AP+ cells. We still 
observed significantly higher AP-positivity in Poly than in Mono cells (Figure 8E).  
 
 
Figure 8 (B-E): Polycistronic delivery of OSKM increased efficiency compared to monocistronic vectors 
B) Representative images of AP+ MRC-5 colonies reprogrammed with either monocistronic (top) or 
polycistronic (bottom) viruses. C) Quantification of SSEA4+ / Tra1-60- and SSEA4+ / Tra1-60+ cells at D7 
and D14 in both monocistronic and polycistronic conditions. Polycistronic reprogramming produced 10-
fold more AP+ colonies in terms of both number (D) and area (E) covered. 
 
 
 
3.2.2 Experimental Design 
 
To measure transcripts in individual cells at various points in the reprogramming 
process, we infected MRC-5 fibroblasts with a polycistronic construct containing all four 
Yamanaka factors (Poly). We then isolated cells by FACS at D4, D7, D11, D14, and 
D21 using the surface markers SSEA4 and TRA-1-60 to enrich for early (SSEA4+/TRA-
1-60-) and late (SSEA4+/TRA-1-60+) reprogramming events, respectively (Figure 8A). 
These cells were sorted into 96-well PCR plates and processed through our single-cell 
pipeline. qPCR was performed using a Fluidigm Biomark against a 96-marker panel 
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(see Methods and Supplemental Table 4). In addition to profiling 80 reprogramming 
cells, we also profiled 16 MRC-5 fibroblasts and 32 H9 and H1 hESCs to represent the 
beginning and end points of the process, respectively. The Poly dataset was trimmed 
for comparison with our previously published MRC-5 Mono data, which contains cells 
sampled at days 4, 7, and 14, evaluated for the expression of 48 genes, all of which 
were present in the larger 96-gene panel analyzed in the Poly experiment [118]. 
 
 
 
 
Figure 8A: Schematic diagram summarizing somatic reprogramming experimental approach 
A) Schematic diagram summarizing somatic reprogramming experimental approach. Cells were infected 
with either Mono or Poly viruses and passaged on D4. Cells were cultured in hESC media until the date 
of harvest when they were dissociated and stained with SSEA4 and TRA-1-60 antibodies. The enriched 
single cells were sorted by FACS into 96-well plates. Following RT and PreAmp, mRNA expression was 
measured on a Fluidigm Biomark and analyzed in R. 
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3.2.3 Reprogramming progression of individual cells in two reprogramming methods 
 
To visualize the progression of cells from the fibroblast to the pluripotent state, 
we used our previously described method of plotting cells based on their relative 
distance from both the fibroblast and hESC populations [118] (Figure 9A) and overlaid 
the surface markers used to isolate the cells. This method is not dependent on the time 
point of collection since progression through the reprogramming process is 
asynchronous and poorly correlated with time [8]. Using this approach, we observed a 
striking increase in the progress of S+T- cells in the Poly condition, with some cells 
overlapping the hESC population, whereas the S+T- Mono cells were only present in 
the first half of the reprogramming trajectory.  
We also observed that the S+T+ Poly cells were very tightly clustered around the 
hESC population, whereas the S+T+ Mono cells spanned a large portion of the 
reprogramming trajectory. The increased progression in the Poly condition was 
accompanied by greater reprogramming synchrony than in the Mono, as revealed by 
the tighter distribution of cells along the reprogramming trajectory maintained over time 
(Figure 9B). The distribution of S+T- Mono cells across the reprogramming trajectory 
broadened between D4 and D14, suggesting that either some cells were initiating 
reprogramming at the later time point, or that not all cells expressing SSEA4 were 
progressing through the process at the same rate, a phenomenon commonly referred to 
as variable latency. This is in contrast to the Poly cells, all of which progressed toward 
an ESC-like transcriptional profile by D14.  
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3.2.4 Generation of a logistic regression model 
 
The period of variable latency may result from the stochastic and uncoordinated 
activation of pluripotency loci required to drive cells toward the pluripotent state [polo 
2012]. Because cells reprogrammed by the polycistronic method progressed more 
uniformly toward the ESC state than by the monocistronic method, we asked whether 
the activation of pluripotency loci or the inactivation of fibroblast-associated loci was 
more tightly coordinated in Poly cells. To answer this question, we improved upon our 
published method [118] (Methods) to model the gene expression changes following the 
reprogramming trajectory from fibroblast to hESC.  
Our new method improved accuracy compared to our previous model, while also 
reducing the number of parameters to minimize bias. We defined the reprogramming 
trajectory by projecting cells into a 2-dimensional PCA space and fitting a polynomial 
curve through the dataset. We then found the shortest distance from each point to the 
curve and assigned a value for that cell along the trajectory. These values were scaled 
from 0 to 1, representing the beginning and end of the process, respectively. For each 
gene in our dataset, we reduced the data to presence/absence calls and fit a logistic 
regression to the data, representing a continuous measure of the probability of detecting 
a given gene over the course of reprogramming. 
  In addition, we gained information about when a gene was activated in the 
majority of samples and how rapidly that change occurred based on the point of 
greatest change in probability and on the steepness of the curve, respectively. An 
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example fit curve is shown in Figure 9C, with dashed lines representing bootstrapped 
confidence intervals around the fit curve. The expectation of this model is that 
conditions where gene expression changes rapidly corresponds to a reprogramming 
process with fewer barriers to the transcriptional activation/inactivation events that are 
necessary to reach pluripotency and more closely resembles a deterministic, rather than 
probabilistic, process.  
 
 
 
 
Figure 9 (A-C): Polycistronic reprogramming exhibited uniform progression and rapid activation of 
pluripotency targets 
A) Reprogramming trajectory of Mono (left) and Poly (right) cells plotted by Euclidean distance from 
fibroblast (x-axis) and hESC (y-axis). Fibroblasts and hESC are marked by pink and green ovals, 
respectively, whereas SSEA4+ and TRA-1-60+ cells are shown in teal and purple, respectively. B) Boxplot 
shows the progression of cells from each condition as a function of time. Both SSEA4+ and TRA-1-60+ 
Poly cells progressed more and were more tightly distributed at D14 than comparable cells from Mono. 
C) Example logistic regression fit of NANOG expression in Mono (red) and Poly (blue) reprogramming 
with bootstrapped confidence intervals (dashed lines). Points represent the binary expression data for 
each cell used in the model fitting.  
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3.2.5 Assessment of two reprogramming methods using logistic regression model 
 
To compare the model fits between conditions, we separated activating and 
inactivating genes and plotted the point of greatest slope and the bootstrapped 
confidence intervals in Figure 9D. We noticed significantly earlier points of activation in 
Poly than in Mono reprogramming (Figure 9E and 9G) for a subset of genes in our 
panel. This included several key pluripotency loci, such as POU5F1, NANOG, and 
DNMT3B, and may, in part, explain the improvement in reprogramming efficiency. 
Interestingly, despite earlier changes in gene expression in Poly cells, the order in which 
these genes were activated/inactivated correlated strongly between the two conditions 
(Spearman r = 0.75). This finding was further supported by the high correlation of gene 
loadings from independent PC analysis of Mono and Poly cells in the PC1 dimension 
(Figure 9F). The loadings provided a measure of when and how strongly each gene 
contributes to progression through the process and, therefore, a strong correlation in the 
loading scores indicated a common path to pluripotency for Mono and Poly 
reprogramming. 
 While the two methods generally followed a similar path to the pluripotent state, 
the activation of a given gene remains a probabilistic event under our model. Thus, the 
order in which an individual cell activates/inactivates these loci is not fixed (i.e., is not 
deterministic). Consistent with this notion, we did not see a narrowing of the activation 
window, as there was no significant difference in the slope of the activation curves 
between conditions (Figure 9H), nor did we observe increased correlation between 
genes in the Poly condition (Figure 9I-J). These results suggest that while some 
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pluripotency genes were activated earlier in the process in Poly reprogramming, neither 
coordinated GRN activity nor deterministic behavior was observed. 
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Figure 9 (D-K): Assessment of two reprogramming methods: Monocistronic and Polycistronic 
D) Box-and-whisker plots depict point of greatest change with confidence intervals for activating and 
inactivating genes. The order of activation was highly correlated between the two conditions (E, 
Spearman r = 0.75), as are the gene loadings from independent PCA analyses (F, Spearman r = 0.8). The 
point of activation was shifted significantly earlier in Poly (G, paired t-test p = 0.002). However, the rate 
of activation as given by the slope of the logistic curve was the same (H, paired t-test p = 0.13). No 
difference in correlation between genes in different conditions was observed when correcting for 
background expectations (I-J) or when using the raw correlation values (K, Pearson = 0.78).  
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3.2.6 Heterogeneity expression of exogenous OSKM reprogramming factors 
 
Given that gene activation/inactivation was only slightly enhanced in polycistronic 
reprogramming and that the overall dynamics of the process appear similar between 
conditions, we looked for other factors that might be contributing to the poor efficiency of 
Mono reprogramming. We hypothesized that OSKM heterogeneity might contribute to 
the low efficiency of Mono reprogramming because the factors are delivered on 
separate viral particles. To test this hypothesis, we included SYBR primers targeting 
synthetic 3’-UTR regions present in the individual OSKM constructs, which allowed us 
to measure the expression of the transgenes in all single cells collected for this 
experiment, in addition to the 48-gene panel analyzed above. Looking at all four factors 
collectively, it is apparent that a vast minority of cells expressed all four exogenous 
factors, with most cells expressing only one or two of the transgenes, including cells 
close to the hESC state (Figure 10A).  
Interestingly, cells that expressed the full complement of reprogramming factors 
were clustered early in the reprogramming trajectory, with no four-factor containing cells 
progressing beyond the 50% mark. By contrast, most cells late in the trajectory 
expressed only one or two factors, typically either OCT4, MYC, or both (Figure 10B). As 
expected, nearly all cells progressing along a previously described alternate trajectory 
away from both fibroblast and hESC lacked expression of all reprogramming factors 
except MYC, illustrating the requirement of OSK expression for productive 
reprogramming.   
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3.2.7 Expression of endogenous and exogenous OSKM reprogramming factors in 
monocistronic reprogramming 
 
The considerable heterogeneity of transgene expression in Mono reprogramming 
cells led us to compare the expression of the endogenous (ENDO) and exogenous 
(EXO) copies of the OSKM factors to see whether cells lacking transgene expression 
exhibited activation of the endogenous copy (Figure 10B). Nearly all Mono cells 
expressed exogenous MYC, whereas only three cells expressed the endogenous form. 
This can probably be attributed to the profound proliferative effects of high levels of 
MYC expression [45,102,103,4], which resulted in the expansion of this population and 
increased the likelihood of their being sampled in our experiment.  
By contrast, EXO-KLF4 was detected in very few cells. However, the 
endogenous form is present in the majority of samples. This is consistent with the role 
played by KLF4 in promoting MET, an essential step in reprogramming that occurs late 
in the process [44–46].   
Moreover, consistent with previous reports that OCT4-high SOX2-low is an 
optimal stoichiometry factor for reprogramming [114,116], we noticed that the 
expression of exogenous OCT4 and SOX2 exhibited opposite patterns, with EXO-SOX2 
expressing cells confined to the first half of the reprogramming trajectory and EXO-
OCT4 cells persisting until the later stages of reprogramming (Figure 10B).  
In addition, many late-reprogramming cells expressed both the ENDO and EXO 
forms of OCT4, further supporting this notion. Surprisingly, approximately 50% of late 
reprogramming cells failed to express either ENDO or EXO-SOX2. In mice, SOX2 is 
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required for entry into the deterministic phase and stabilization of the pluripotent state. 
The absence of SOX2 in some of our late reprogramming cells raises the question as to 
whether or not these cells will successfully reprogram. In addition, it is unclear whether 
these cells were capable of progressing to the late stages of reprogramming in the 
absence of SOX2 expression, or whether the SOX2 virus was prematurely inactivated 
prior to completing the process.  
 
 
 
 
Figure 10 (A-B): Expression of OSKM transgenes was heterogeneous in monocistronic reprogramming 
A: Reprogramming trajectory overlaid with number of transgenes expressed within each cell as 
determined by SYBR green qPCR. Few cells expressed all four factors, and most contained only one or 
two. B: Trajectory plots with total exogenous and/or endogenous OSKM content displayed. Splines of 
endogenous and exogenous factor content along the trajectory are shown above. 
 
 
  
  60 
3.2.8 Transcriptional analysis of low-GFP-expressing reprogramming cells 
 
To answer this question, we took advantage of the fact that our monocistronic 
OSKM vectors coexpress GFP along with each reprogramming factor, enabling the 
selection of cells with low viral content as indicated by low GFP expression. These cells 
were sorted by FACS and we assessed their transcriptional profile using our 48-gene 
panel.  
When added to our reprogramming trajectory (Figure 10C), these cells appeared 
nearly identical to fibroblasts, and both S+T- and S+T+ Low-GFP cells exhibited 
impaired progression compared to their High-GFP counterparts (Figure 10D). This 
suggests that these cells failed to respond to the OSKM cocktail. However, principal 
component analysis (PCA) revealed that the Low-GFP cells were a distinct population 
and separate from non-reprogrammed fibroblasts along the PC3 axis (Figure 10E). This 
separation was due to the expression of the late reprogramming genes ZIC3 and OTX2 
in these cells, despite the failure to activate core pluripotency loci including OCT4, 
NANOG, SOX2, and ZFP42 (REX1), and the persistence of fibroblast gene expression 
(LOX and LUM) (Figure 10F).  
The expression of ZIC3 and OTX2 in the Low-GFP population indicates that 
these cells reached the late stages of reprogramming, but collapsed back to a 
fibroblast-like state due to premature loss of transgene expression. Alternatively, the 
cells may have been infected with only a subset of the reprogramming factors, and 
therefore were following a reprogramming trajectory not typical of cells receiving the full 
complement of OSKM.  
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Figure 10 (C-F): Mapping of High- and Low-GFP-expressing reprogramming cells. 
Mapping of High- and Low-GFP-expressing cells on reprogramming trajectory demonstrates that Low-GFP cells 
exhibited a fibroblast-like expression pattern (C) and failed to progress toward pluripotency as compared to 
High-GFP cells (D). Principal Component Analysis reveals that Low-GFP cells were distinct from all other cells in 
our experiment (E). This was due to the expression of the late reprogramming genes ZIC3 and OTX2 despite the 
failure to activate core pluripotency genes and the persistence of fibroblast gene expression, as shown in (F). 
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3.2.9 Somatic reprogramming using three-factor combinations of SKM, OKM, OSM, and OSK  
 
We tested this hypothesis explicitly by generating all possible 3-factor 
combinations (SKM, OKM, OSM, and OSK), removing each factor from the STEMCCA 
polycistronic vector, and measuring the reprogramming trajectory of the infected cells. 
Attempts to reprogram cells with any of these three-factor combinations failed to 
produce any AP+ colonies and resulted in a significant reduction in SSEA4+ and TRA-
1-60+ cells.  
These cells also failed to productively reprogram, moving away from fibroblast, 
but not toward hESC (Figure 11A), as evidenced by the minimal expression of both 
fibroblast and pluripotency genes in our panel. However, this reduced expression was 
not caused by a lack of cell viability or the induction of apoptosis, indicating that these 
cells followed a trajectory that could not be measured using our existing marker set. K-
means clustering of the 3-factor reprogramming conditions along with the MRC-5 Mono 
dataset (Figure11B) revealed that this trajectory is equivalent to the Alternate trajectory 
we identified previously [20], and suggests that Mono cells in this Alternate group were 
also cells that failed to receive the full complement of OSKM (Figure11C).  
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Figure 11: Premature inactivation of the individual OSKM factors is a major weakness of 
monocistronic reprogramming. 
A: Reprogramming the trajectory of cells reprogrammed with polycistronic virus carrying all possible 
three-factor combinations (SKM, OKM, OSM, and OSK), overlaid with the S+T- and S+T+ coverage 
ellipses from MRC-5 Mono reprogramming. All cells moved away from fibroblast, but not towards hESC, 
indicating a failure to successfully reprogram.  
B: Overlaying all three-factor reprogramming conditions with MRC-5 monocistronic reprogramming 
shows that three-factor reprogramming sent cells to the ‘Alternate’ group, as defined in our previous 
publication. Groups were determined using k-means clustering with k=4.Other groups include Early, 
Mid, and Late groups along the path to pluripotency. 
C: Quantification of the number of cells found in each group described in (B). 
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3.3 Discussion 
 
In this chapter, we performed a side-by-side comparison of polycistronic and 
monocistronic reprogramming in human fibroblast cells. Our primary findings are that 
reprogramming by the polycistronic method resulted in a 10-fold increase in efficiency 
over monocistronic reprogramming, and that this difference was due in part to the 
premature inactivation of the individual OSKM factors in the monocistronic condition. 
While it has been previously documented that factor expression decreases over the 
course of reprogramming [15,122], this was believed to represent cells entering the 
pluripotent state. Inactivation of the reprogramming factors is generally considered to be 
a late event in the reprogramming process, and is associated with the generation of 
stable iPSC lines [36,48].  
Our study represents the first report that premature inactivation of OSKM can 
occur amid productive reprogramming and results in a collapse of cells back to a 
fibroblast-like state. These cells exhibited signatures of productive reprogramming, in 
particular, the expression of the late reprogramming genes ZIC3 and OTX2. However, 
they failed to activate the core pluripotency circuitry and continued to express markers 
of the fibroblast state. We excluded the possibility that these failed reprogramming 
events arose from cells receiving an incomplete complement of OSKM by 
demonstrating that cells lacking any one of the four factors failed to reprogram.  
Our analysis of transgene content in productively reprogramming cells 
demonstrates that a particular stoichiometry is optimal for pushing cells toward the 
pluripotent state. Specifically, high levels of OCT4 and low levels of SOX2 were favored 
  65 
in cells that reached an ESC-like transcriptional profile, whereas KLF4 expression was 
consistent throughout the process, as previous reports have stated [114,119]. The 
robust detection of MYC throughout the process was expected due to the rapid 
expansion of MYC expressing cells, and this increase in cell cycling has been shown to 
greatly enhance the efficiency of reprogramming [103]. Importantly, it has been 
previously shown that there is no selective inactivation of any of the four reprogramming 
factors in iPSCs [23]. Therefore, the differences we see in factor content reflect a bias 
for particular OSKM combinations as we select for late reprogramming events (i.e., 
TRA-1-60+ cells) rather than preferential inactivation of any one factor.  
By examining the trajectories followed by cells reprogrammed with either Mono 
or Poly viruses, we noticed that cells from the Mono condition exhibited a delay in the 
activation of several pluripotency loci, including POU5F1, NANOG, DNMT3B, and 
LIN28, compared to Poly reprogramming. The period preceding the activation of the 
core pluripotency circuitry is referred to as latency, which is believed to be a major rate-
limiting step in generating iPSCs. Our observation that latency was increased in the 
monocistronic conditions with relatively lower efficiencies supports this notion and, to 
our knowledge, is the first time that this phenomenon has been measured between 
distinct conditions. 
Our study demonstrates that different reprogramming paradigms have the 
greatest effect early in the process prior to the onset of pluripotency gene expression. 
Once expression is initiated, cells from all conditions follow a similar path to the 
pluripotent state as long as OSKM expression is maintained. The establishment and 
maintenance of factor expression is a critical challenge in monocistronic reprogramming 
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because not all cells receive the full OSKM cocktail, nor do they maintain their 
expression throughout the entire process in all cells. This is a key advantage of the 
polycistronic method, which ensures delivery of all four factors on a single construct. 
Our ability to make these conclusions relies on the single-cell resolution of our analysis 
and the comparison between multiple reprogramming conditions, and demonstrates the 
need for rigorous comparison between protocols in order to determine the effect of 
procedural variables on the reprogramming process.  
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Chapter 4 Comparison between MRC-5 and BJ fibroblast cells using polycistronic 
OSKM reprogramming factors  
4.1 Introduction 
 
Most studies to date have focused on reprogramming fibroblasts thanks to their 
simplicity of isolation. However, dozens of other cell types have been successfully 
reprogrammed [7,9,11,12]. The starting cell type has been demonstrated to have a 
significant effect on both the efficiency of the process and the differentiation capacity of 
the resulting iPSCs [5,68,101]. There is evidence to suggest that these effects are 
caused by unique epigenetic landscapes in different cell types that can affect the 
accessibility of pluripotency loci, and consequently their ability to be activated by 
reprogramming factors [79,55,54,123]. This epigenetic landscape also results in a 
‘memory’ of the cell’s starting identity, making differentiation back to the cell type of 
origin more efficient than generation of more therapeutically relevant alternatives 
[82,124,125]. Thus, the starting cell type can have a dramatic influence on the outcome 
of the reprogramming process, but again, no analysis of whether this affects the 
acquisition of pluripotency has been performed. 
Using the mathematical modeling and precise pluripotency progression 
measurement discussed in previous chapters, it is a logical next step to compare 
OSKM-mediated reprogramming of two fibroblast tissues that have similar transcription 
profiles but different chromatin states. Comparing the gene expression and activation 
dynamics during the reprogramming process of these two fibroblast cell types will show 
how gene-specific chromatin states in the starting cells control gene activation dynamics 
during the reprogramming process, and this comparison can subsequently be used to 
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dissect the precise mechanisms and chromatin modifications that limit the conversion 
rate and efficiency of somatic cells to iPSCs. 
4.2 Results 
 4.2.1 Comparing the dynamics of pluripotency gene expression in BJ and MRC-5 
fibroblast cell lines 
 
Having determined that premature inactivation of the individual OSKM factors 
was a major weakness of Mono reprogramming, we then compared the dynamics of 
pluripotency gene expression in two fibroblast cell lines, BJ and MRC-5, using the 
polycistronic method. To this end, we compared MRC-5 and BJ cells reprogrammed 
with polycistronic OSKM and analyzed the expression of 96 genes as described above. 
In our system, BJ fibroblasts exhibited approximately 3X greater efficiency than MRC-5, 
as determined by the number of AP+ colonies at days 7, 14,and 21. Thus, we next 
sought to determine whether this difference in efficiency was evident in the trajectories 
of each reprogramming cell type or in the expression of individual genes. Comparing the 
progression of cells over the course of reprogramming showed little difference in the 
S+T- and S+T+ cells from both cell types and, as expected, we found that S+T+ cells 
progressed uniformly toward pluripotency whereas S+T- exhibited a broader distribution 
due to variable latency (Figure 12A-B).  
 In addition, visualizing the trajectories in PCA space showed that most of the 
process appears identical among cell types in the first two PC dimensions, which 
cumulatively capture approximately 35% of the variance (Figure 12C). However, 
inclusion of the PC3 dimension (5% variance) revealed a slight divergence between the 
two trajectories early in the process, followed by convergence near the hESC state 
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(Figure 12D). This observation was reiterated by plotting each cell type side by side in 
its own PC space. An initial comparison of the PCA showed that both cell types 
exhibited a similar distribution of reprogramming intermediates as determined by the 
amount of variation captured by each PC dimension (Figure 12E). Comparison of the 
gene loadings between the MRC-5 and BJ PC analyses revealed a strong correlation in 
the PC1 (Spearman r = 0.95) and PC2 (Spearman r = 0.72) dimensions, whereas 
correlation in the PC3 dimension was weak (Spearman r = 0.59) (Figure 12F). This 
again suggests that nearly identical gene expression dynamics exist between the two 
cell types, along with subtle differences. 
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Figure 12: MRC-5 and BJ fibroblast trajectories diverged early and converged late in reprogramming. 
Plotting the reprogramming progression of each cell type as a function of time shows that both MRC-5 
and BJ S+T+ cells were broadly distributed along the trajectory, but progressed toward hESC over time 
(A). The same analysis of S+T+ cells shows a tighter distribution of cells at all time points regardless of 
cell type (B). PCA shows that MRC-5 and BJ fibroblasts followed nearly identical reprogramming 
trajectories in the first two components (C). However, PC3 reveals a divergence of the trajectories early 
in reprogramming, followed by convergence later in the process (D). This separation is minimal as PC3 
only captures approximately 5% of the variability (E).  
(F) Comparison of the gene loadings between the MRC-5 and BJ PC analyses in PC1 (Spearman r = 0.95), 
PC2 (Spearman r = 0.72), and PC3 (Spearman r = 0.59) demonstrates that the same genes defined the 
trajectories in both cell types, suggesting a common route to pluripotency.  
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4.2.2 Modeling approach to compare the point of activation between genes in two cell lines 
 
To determine which genes specifically contribute to the minor differences in the 
reprogramming trajectories of BJ and MRC-5 fibroblasts, we utilized our model to 
compare the point of activation of genes between conditions. Example fit curves for 
increasing and decreasing genes are shown in Figures 13A and 13E, respectively. We 
again use box-and-whisker plots to represent the mean and bootstrapped confidence 
intervals of the fit curves for both activating and inactivating genes (Figures 13B and 
13F). A delay in the activation of several genes (Figures 13B and 13D, highlighted in 
red) was immediately apparent in MRC-5 cells early in the trajectory. These included 
key pluripotency genes such as NANOG, POU5F1, DNMT3B, and LIN28. As expected, 
genes late in the trajectory exhibited nearly identical activation patterns, consistent with 
the observation that the trajectories converge near the ESC state. We also observed 
delayed inactivation of the fibroblast marker LUM and a MET inhibitor, SNAI2, in MRC-5 
cells (Figure 13F). For both activating and inactivating genes, we saw the same degree 
of correlation between genes in both conditions (Figures 13C and 13G), indicating that 
the interactions between genes were consistent in BJ and MRC-5 reprogramming. 
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Figure 13: MRC-5 and BJ fibroblasts exhibited subtle differences in their gene activation dynamics. 
Logistic regressions were used to model the probability of detecting a given gene along the 
reprogramming trajectory. Example model fits for activating and inactivating genes are shown in (A) 
and (E), respectively. Box-and-whisker plots are used to represent the mean and bootstrapped 
confidence intervals of the fit curves for both activating (B) and inactivating genes (F), and indicate that 
a small group of genes (B and D, highlighted in red) exhibited a delay in expression in MRC-5 fibroblasts. 
However, the overall order of activation/inactivation was highly correlated among cell types (D and H). 
We also observed a similar correlation among activating genes in both conditions (C), although 
decreasing genes appeared more tightly regulated in BJ than in MRC-5 (H). 
  73 
4.3 Discussion 
 
It is commonly believed that latency results from the remodeling of the epigenetic 
landscape to allow the activation of pluripotency loci, and it is expected that different 
factor stoichiometries or starting cell types affect the rate at which this process occurs 
[17,29,31,47,49,50]. If true, this would imply that BJ cells have a more permissive 
chromatin state at some loci than MRC-5 fibroblasts, facilitating their activation. A 
rigorous comparison of reprogramming in cell types with divergent chromatin states 
would directly address this hypothesis and represents an attractive area of research.  
Despite the differences observed early in the process, cells from all conditions 
activated pluripotency genes in a similar probabilistic order following the latency period, 
suggesting a common mechanism in establishing pluripotency. The convergence on a 
common trajectory late in the process resembles the deterministic phase described by 
Buganim et al. However, in our system these gene activation events were independent 
and probabilistic and we, therefore, do not believe that our observation represents a 
strictly deterministic process. It was also somewhat surprising that different 
reprogramming conditions resulted in similar reprogramming trajectories given the 
variation in quality and differentiation potential of iPSCs derived from these different 
methods [6,51]. This implies that iPSC phenotype variation resulted, not from 
differences in how the pluripotency network is established, but probably from 
differences that were not analyzed in our study. This may result from differential 
expression of genes whose expression alters the iPSC phenotype, or it may occur at 
the epigenetic level, as has been shown for the Dio-Dlk3 locus in mice [116]. 
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In contrast to the similarities between BJ and MRC-5 at the transcript level, the 
surface markers SSEA4 and TRA-1-60 labelled slightly different populations between 
cell types. While the reason for this is unclear, it illustrates the impact of cell type on 
selecting informative biomarkers to isolate cells from different parts of the 
reprogramming process. SSEA4 and TRA-1-60 are also unique in that they are the only 
markers examined in our study that exhibit a strict order of activation: SSEA4 turns on 
before TRA-1-60, and all TRA-1-60+ cells are also SSEA4+. This is very different from 
the probabilistic order observed at the transcript level for most genes in our panel and it 
raises the question as to whether the process is more highly ordered or deterministic at 
the level of protein expression. Recently, several groups have begun to explore the 
dynamics of the proteome during reprogramming; however, this has not yet been 
coupled with transcriptional analysis, and all studies to date have been performed in 
mice. This remains an important area of study in the field of reprogramming.  
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Chapter 5 Conclusion and Future Directions 
5.1 Conclusion 
 
Even now, many years after the discovery of somatic reprogramming using 
OSKM factors, a detailed mechanistic understanding of reprogramming remains elusive. 
Numerous studies suggest that reprogramming to pluripotency occurs in two phases: a 
prolonged stochastic  phase followed by a rapid deterministic phase [77], which is 
represented by the high expression of endogenous SOX2 transcript and low or null 
expression of exogenous SOX2 transcripts in mice [72]. The primary objective of this 
thesis was to provide a precise mathematical framework that describes the dynamic of 
pluripotency gene expression during somatic reprogramming, and to present a precise 
model that describes the stochastic phase of reprogramming, in the hope of enabling 
the measurement and detailed mechanistic dissection of various reprogramming 
methods and treatments that enhance the rate of reprogramming efficiency. 
Using single-cell analysis, human fibroblast cells undergoing reprogramming at 
various time points, were analyzed with a 96-marker panel. With these data, we were 
able to construct a Euclidean diagonal between the fibroblasts and the hESC 
transcriptional data profile that accurately measured a given reprogramming cell’s 
progression toward hESC. Using this metric, we were able to show that partially 
reprogrammed cells infected with OSKM factors followed either alternative trajectories 
or productive trajectories, and that these two pathways could be distinguished by the 
organized expression of a small group of chromatin modifiers. In addition, using 
Euclidean space analysis, principal component analysis, and Gaussian distribution, we 
  76 
showed that the stochastic phase of reprogramming in human fibroblasts is an ordered, 
probabilistic process with gene-specific dynamics. 
Furthermore, our comparisons of two the most widely used reprogramming 
methods, the monocistronic and polycistronic OSKM virus cassettes, confirmed that the 
polycistronic OSKM virus cassette significantly increased reprogramming efficiency 
compared to the monocistronic OSKM virus cassette [48], and we are the first to 
demonstrate that this difference is caused in part by the premature inactivation of the 
individual OSKM factors in the monocistronic condition. We also demonstrated that 
premature inactivation of OSKM can occur amid productive reprogramming and results 
in a collapse of cells back to a fibroblast-like state. Conversely, the gene expression 
dynamics during both reprogramming methods were not found to contribute to 
reprogramming efficiency. 
Finally, we compared two human fibroblast cell lines: BJ and MRC-5. Our results 
showed that the two cell lines diverge at the beginning of the reprogramming 
trajectories, but converge at the end of these trajectories. The minor differences in the 
early reprogramming trajectories were contributed by the variation in expression latency 
of activating key pluripotency genes and by the inactivation of fibroblast genes. 
Nonetheless, even with these subtle differences, the two cell types have nearly identical 
gene expression dynamics and gene interactions are consistent in BJ and MRC-5 
reprogramming.  
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5.2 Future Studies 
 
  This work presents the mechanistic description and modeling of gene expression 
dynamics during the stochastic phase of reprogramming, which provide an essential 
quantitative framework for dissecting key rate-limiting steps and will enable the 
mechanistic dissection of interventions known to accelerate or enhance the efficiency of 
the reprogramming process. In addition, the early stochastic phase of reprogramming is 
governed by c-MYC-responsive chromatin modifiers, and successful reprogramming 
requires the gradual erosion of epigenetic barriers to activation of the pluripotency GRN 
by OSKM. Furthermore, this work demonstrates that different reprogramming 
paradigms have the greatest impact prior to the onset of pluripotency gene expression. 
Once pluripotent gene expression is initiated, cells from the various conditions we 
measured follow a similar path to the pluripotent state as long as OSKM expression is 
maintained. 
While these findings are important, my work represents only a first step in 
dissecting complicated and largely unknown reprogramming mechanisms. Therefore, 
further studies are necessary to enhance our understanding of these mechanism. Such 
studies include expanding the gene marker panel from 96 to all genes known to be 
expressed in humans through RNAseq technology, and developing an enhanced model 
that precisely describes the behavior of expressed transcripts.  
Additionally, a careful assessment of reprogramming in cell types with divergent 
chromatin states and epigenetic landscapes will specify the order and exact identity of 
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the chromatin modifications that are required for successful and efficient 
reprogramming.  
Finally, the investigation of protein expression dynamics, coupled with 
transcriptional analysis during reprogramming, will highlight the mechanistic 
involvement of transcriptional and translational regulation. 
Using single-cell transcriptional analysis to provide a mechanistic understanding 
and modeling of gene expression dynamics during the rate-limiting phase of 
reprogramming will help to enable a faster and more efficient reprogramming process 
and will contribute greatly to the development of therapeutically relevant and safely 
induced pluripotent stem cells. It will also help researchers to have a complete tool for 
measuring and comparing changes in transcriptional dynamics among various 
treatments during somatic reprogramming. Ultimately, this tool will provide a needed 
support to researchers for developing a somatic reprogramming protocol involving 
sequential targeting, which targets specific pathways at specific time points during the 
reprogramming process. 
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Chapter 6 Materials and Methods 
6.1 Monocistronic OSKM mediated somatic reprogramming 
6.1.1 Production of Retrovirus: 
Retroviral vectors (pMIG) containing OCT4, SOX2, KLF4, c-MYC (OSKM) along 
with helper plasmids (VSV-G and Gag-pol) were obtained from I.H.Park (Yale 
University, New Haven, CT). To generate viral particles, individual retroviral vectors 
were co-transfected with VSV-G and Gag-pol into 293T cells seeded at 2 x 106 cells per 
10-cm2 using FuGENE 6 transfection reagent (Roche Applied Science). After 72-hour 
induction, supernatants were collected, filtered through 0.45µm filter and concentrated 
using Vivaspin 300,000 MWCO PES filter columns (Sartorius). Viral titer was 
determined using FACS analysis for GFP expression (encoded in the pMIG vector). An 
MOI of 5 was used for all experiments.  
6.1.2 Cell culture and Fibroblast Reprogramming: 
MRC-5 human fetal lung fibroblasts were obtained from I.H. Park (Yale 
University, New haven, CT). Briefly, MRC-5 cells were expanded in human fibroblast 
(hFib) media (DMEM (Gibco), 10% FBS (Milipore), 1% L-glutamine (Gibco) and 1X 
Penn-Strep (Gibco). One day prior to infection, 1 x 105 MRC-5 fibroblasts were seeded 
into one well of a 6-well dish containing hFib media. The next day, cells were incubated 
in RI media (MEM alpha (Mediatech) and 10% FBS (Millipore)) containing 5ug/mL 
protamine sulfate (Sigma) and OSKM virions for 24hrs followed by replacement with 
fresh RI media. Cells were cultured for 72hrs post-infection and passaged to two 10cm2 
dishes pre-seeded with 7.5 x 105 inactivated feeders in hESC media supplemented with 
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10µM Y-27632 (Calbiochem). After passaging, fresh hESC media was added daily until 
the end of the experiment. H9 human embryonic stem cells (WiCell) were maintained in 
hESC media (DMEM F-12 (Gibco), 20% Knockout-Serum Replacement (Gibco), 1% L-
Glutamine (Gibco), 1% Non-Essential Amino Acids (Gibco), 5µM β-mercaptoethanol 
(Gibco), and 2ng/mL b-FGF) and passaged using standard methods.  
6.1.3 Antibody Staining and FACS Sorting of Reprogramming Cells: 
Reprogramming MRC-5 fibroblast cells were harvested with 1mL Accumax 
(Millipore) per well (6-well dish) for 15 minutes at 37°C. Cells were pelleted, washed 
with PBS (Gibco) and wash buffer (2% FBS in HBSS (Invitrogen)), and resuspended in 
wash buffer. Cells were then stained using antibodies for SSEA4 (Biolegend, Cat# 
330405) TRA-1-60 (Biolegend, Cat# 330605), washed 3 times and resuspended in 
FACS buffer (1% FBS in PBS). For FACS, cells were live/dead stained and gated on 
GFP and appropriate surface markers as indicated and single cells sorted into 96 well 
PCR plates. All FACS was performed using a BD Bioscience FACS Aria II. 
6.1.4 Quality Control and Single cell qRT-PCR: 
Single cell qRT-PCR was performed as previously described [92]. Briefly, single 
cells were lysed and denatured by incubating at 70°C for 10 minutes and then cooled to 
4°C. Cells were then reverse transcribed and pre-amplified using gene specific primers 
(0.25X pooled TaqMan assays) and analyzed by qPCR. qPCR was performed using 
TaqMan chemistry in 384 well plates on an ABI 7900HT Fast Real-Time system. 
Average cycle threshold (Ct) values obtained from qPCR reactions were normalized to 
GAPDH (∆Ct), and inverted by taking the (40 – ∆Ct) value. To reduce technical error 
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and ensure robust sample quality, all cells with a GAPDH Ct value of 25 or greater were 
excluded from further analysis. TaqMan assays for endogenous OCT4, SOX2, KLF4 
and c-MYC were directed against the 3’-UTR region of the transcript, which is distinct 
from the synthetic UTRs incorporated in the viral OSKM transgenes, conferring their 
specificity to the endogenous transcripts.  
6.1.5 Marker Panel Selection 
Genes selected for inclusion in our 48 marker panel were chosen based on 
several criteria. For pluripotency and chromatin modifier genes we selected those 
whose role in the establishment or maintenance of the pluripotent state was well 
documented and experimentally validated. This decision was further informed using the 
dataset of Dowell et. al. [126] which assigns a self-renewal score to genes based on 
their integration in the pluripotency gene regulatory network (as determined by direct 
binding of O, S, K and/or M) as well as their degree of co-expression with well-
established pluripotency genes. Fibroblast genes were selected based on their 
expression in fibroblasts and absence from hESCs as determined in [96,127]. 
6.1.6 Data Analysis: 
Distance was determined by reducing gene expression to 0(undetected) and 
1(detected, Ct < 40) and calculating the average Euclidean distance for each cell to the 
FIB and PLURI groups, ignoring self-comparisons. Similarity was computed for each 
group distance by taking the ratio of the distance between FIB and PLURI minus each 
cell’s distance to the group in question, over the distance between FIB and PLURI 
minus the average distance of that group to itself. The average of the similarity to 
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PLURI and the complement of the similarity to FIB was taken as an estimate of the 
progression of each cell along the PLURI trajectory. Distance off of the trajectory was 
taken as the Euclidean distance from the FIB and PLURI similarities to the trajectory 
value. 
PCA-based SOM analysis was performed in JMP, Version 10 (a SAS 
product)[128] using a 5-by-1 matrix and visualizing on a biplot (PC1 vs PC2). Cells 
within the “Alt” group were considered to be outliers (as described above) and were 
excluded from subsequent analysis, unless otherwise indicated. Hierarchical clustering 
was also performed in JMP, using Ward’s method with no standardization, on (40-∆CT) 
values. Coverage ellipses on the Euclidian distance graphs represent 90% coverage of 
the data points from the group indicated. For correlation analysis Pearson’s correlation 
coefficients within a defined SOM grouping were taken for the entire 48x48 matrix of 
genes analyzed in this study. Network graphs were constructed in Cytoscape using a 
force-directed layout derived from the top 100 Pearson correlations between all of the 
cells, excluding outliers, in our analysis (n = 117). 
6.1.7 Model Generation: 
To generate accurate models, the data was first interpolated to generate a high 
resolution training set. The entire sample population was included, except for outliers 
considered as the cells with the highest distance off of the trajectory (10%, N=17). The 
training data represented the percentage of cells expressing a gene at any point along 
the PLURI trajectory, and was measured by uniformly placing overlapping bins of fixed 
width across the range and directly counting the number of cells expressing each gene. 
Models were generated to then predict the percentage expressing at any trajectory 
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location. ‘Uniform’ models were generated by assigning a ‘Baseline’ value at the start of 
the trajectory (=0), and fixing a slope such that a straight line passed from the ‘Baseline’ 
to the value at the end of the trajectory (=1). ‘Normal’ models were then fit to this data 
using the ‘optim’ function in R, attempting to minimize the mean squared error, using the 
constraint,  and the following form: 
 
In order to verify model quality and compare fitting between different models, AICc was 
calculated and a bootstrapping test was performed. AICc was calculated by:  
 
where n is the effective number of sample points present in the original data, k is the 
number of free model parameters, and MSE is the mean squared error from the model 
prediction to the training data. Bootstrapping was performed by repeatedly simulating 
the training data but using only n bins and randomly resampling a fixed number of cells 
from each bin’s range. The error between the model prediction and the resampled data 
was compared to the expected error using an F-test to predict if the error induced by 
lack-of-fit exceeded the pure error of the data by a significant level, and this was tracked 
as a percentage of all tests done against the model. 
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6.1.8 Correlation Analysis 
First, simulated populations of an equal size were generated by sampling a set of points 
along the reprogramming progression axis such that they matched the distribution of 
values in the original dataset. For each sampling point, representative of a single 
simulated cell, each gene was set to detected or undetected independently, using the 
frequency curves generated from our Gaussian model. Pearson correlation coefficients 
were then computed for this reference population, and averaged over repeated runs 
(n=1000000). Differences in correlation between this background dataset and those 
calculated for our observed data  were then tested for significance using the ‘r.test’ 
function of the R package ‘psych’.  
6.2 Comparison between Monocistronic and Polycistronic reprogramming 
methods and two cell types; BJ and MRC-5 fibroblasts. 
 
6.2.1 Vector plasmid construction and Design 
 
Monocistronic reprogramming retroviral vectors (pMIG) containing OCT4, SOX2, KLF4, 
c-MYC (OSKM) along with helper plasmids (VSV-G and Gag-pol) were obtained from 
I.H.Park (Yale University, New Haven, CT). The Polycistronic lentiviral vector 
(STEMCCA-LoxP) containing all four reprogramming factors in single cassette, along 
with helper plasmids (VSV-G, Gag-pol, TAT and Rev) were generous gift from G. 
Mostoslavsky (Boston University School of Medicine, Boston MA). The 3-factor 
polycistronic vectors were constructed by modifying STEMCCA-LoxP as follows. First, 
we removed either the OCT4-F2A-KLF4 or SOX2-E2A-cMYC cassette from the 
STEMCAA-LoxP vector using the NotI/BamHI or NdeI/BsaBI sites, respectively. The 
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deleted cassettes were then replaced with one of the two original cDNAs to generate a 
3-factor-containing polycistronic vector. The individual human cDNAs encoding the four 
reprogramming factors were amplified from the STEMCCA-LoxP vector using following 
primers: OCT4 NotI Poly F (5’-GCGGCCGCATGGCGGGACACCTGGCTTC-3’); OCT4 
BamHI Poly R (5’-GGATCCTCAGTTTGAATGCATGGGAGAG-3’); KLF4 NotI Poly F (5’-
GCGGCCGCATGGCTGTCAGCGACGCGCTG 3’); KLF4 BamHI Poly R (5’-
GGATCCTTAAAAATGCCTCTTCATGTG-3’); Sox2 NdeI Poly F (5’-
CATATGATGTACAACATGATGGAGACGG-3’); Sox2 BsaB1 Poly R (5’-
GATCCTAATCCTATGTGTGAGAGGGGCAGTGTG-3’); c-Myc NdeI Poly F (5’-
CATATGATGCCCCTCAACGTTAGCTTCACC-3’); c-Myc BsaB1 Poly R (5’-
GATCCTAATCTTACGCACAAGAGTTCCGTAGCTG-3’).  
6.2.2 Production of Reprogramming virus 
 
Simultaneous delivery of the four reprogramming factors OCT4, SOX2,KLF4 and c-
MYC [1] and delivery of three reprogramming factors (SKM, OKM, OSM, OSK)  were 
achieved  using the STEMCCA-LoxP polycistronic lentiviral vector. Virus was produced 
by cotransfection of STEMCCA-LoxP along with helper plasmids VSV-G, Gag-pol, Rev 
and TAT into 293T cells in 5 x 10cm2 dishes. 72hrs post-transfection, supernatant was 
harvested and concentrated to 1mL using Vivaspin 300,000 MWCO PES filter columns 
(Sartorius), and 100ul of the concentrated virions were used for each reprogramming 
experiment. Individual OSKM retrovirus (monocistronic) were generated as previously 
described [118] and infected at an MOI of 5 for all reprogramming experiments. 
6.2.3 Cell culture and fibroblast Reprogramming 
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BJ neonatal foreskin fibroblasts were purchased from Stemgent and expanded in hFib 
media (DMEM, 10% FBS, 1% L-glutamine, 1% Penn/Strep) to passage 9. For 
monocistronic, polycistronic and 3-factor reprogramming experiments, 1 x 10^5 BJ cells 
were plated into 1 well of a 6-well dish in RI media (MEM alpha (Mediatech) and 10% 
FBS (Millipore)) containing 5ug/mL protamine sulfate (Sigma) and either STEMCAA-
LoxP virions or individual pMIG-OSKM virions for 24hrs followed by replacement with 
fresh RI media. 72hrs post-infection, cells were split into 10cm2 dishes pre-seeded with 
7.5 x105  irradiated MEFs. Cells were split 1:2 for all monocistronic experiments and 1:3, 
1:10, 1:20 and 1:30 for day 7,11,14 and 21 polycistronic reprogramming, respectively. 
One day after the split, cells were switched to hESC media (DMEM F-12 (Gibco), 20% 
Knockout-Serum Replacement (Gibco), 1% L-Glutamine (Gibco), 1% Non-Essential 
Amino Acids (Gibco), 5µM β-mercaptoethanol (Gibco), and 2ng/mL b-FGF) 
supplemented with 10µM Y-27632 (Calbiochem). Cells were then maintained in hESC 
media until the time of harvest. H1 and H9 human embryonic stem cells (WiCell) were 
maintained in mTeSR media (Stem Cell Technologies) on matrigel treated 6 well plates 
and passaged as single cells using trypsin and hESC Cloning and Recovery 
Supplement (Stemgent). 
6.2.4 Antibody staining and FACS sorting Reprogramming cells 
 
For both reprogramming paradigms, cells were harvested with 1mL 0.01% Trypsin 
(Gibco) per 10cm2 dish for 5 minutes at 37°C. Cells were pelleted, washed twice with 
staining buffer (2% FBS in HBSS (Invitrogen)), and resuspended in 100uL staining 
buffer. For monocistronic reprogramming, cells were stained with either biotinylated α-
SSEA4 (Biolegend, 330404) or α-TRA-1-60 (330604) followed by Brilliant Violet-421 
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secondary (Biolegend 405226) and APC α-MEF (Miltenyi). For polycistronic 
experiments, cells were co-stained for SSEA4 as above, and α-TRA-1-60 APC 
(Biolegend, 330605) and APC α-MEF (Miltenyi). After staining cells were washed 3 
times and resuspended in FACS buffer (1% FBS in PBS) prior to sorting. Cells from the 
indicated time points were gated on SSEA4 and/or TRA-1-60 expression and single 
cells were sorted into 96 well plates using a BD FACS Aria II. Monocistronic cells were 
additionally gated for GFP-positive cells to select for presence of the OSKM viruses 
6.2.5 AP staining and surface markers Quantification 
 
Alkaline phosphatase staining was performed in 6-well plates using the alkaline 
phosphatase detection kit (Millipore) per the manufacturer's instructions. Plates were 
images in bright field on an Olympus SZ61 dissecting microscope and colony number 
and total area were counted using ImageJ.  To accurately quantify the percentage of 
SSEA4+ and TRA-1-60+ cells from each condition,  we stained with biotinylated α-
SSEA4 (Biolegend, 330404) or α-TRA-1-60 (Biolegend,330604) primary, followed by 
Brilliant Violet-421 secondary (Biolegend 405226) and APC α-MEF (Miltenyi) at 
reprogramming day 14 and 21. All experiments above were performed triplicate. 
6.2.6 Cell death analysis 
 
To evaluate the degree of cell death due to inactivation of reprogramming factors, BJ 
fibroblast cells were reprogrammed using both polycistronic and 3-factor reprogramming 
vectors and cells were analyzed at day 14 and day 21 in triplicate. Cells were stained 
either with propidium iodide or α-cleaved Caspase-3 (Cell Signaling, 9664P) to measure 
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live/dead and apoptosis, respectively. All staining was performed at the manufacturer's 
recommended dilution and measured on a BD FACSCalibur instrument.  
6.2.7 Quality control and single cell qRT-PCR 
 
Single cell qRT-PCR was performed as previously described [118]. Briefly, single cells 
were lysed and denatured by incubating at 70°C for 10 minutes and then cooling to 4°C. 
Cells were then reverse transcribed and pre-amplified for 16 cycles using gene specific 
primers (0.25X pooled TaqMan assays) and analyzed by qPCR on the Fluidigm 
Biomark platform using 96.96 Dynamic Arrays and Taqman chemistry. To reduce 
technical error and ensure robust sample quality, all cells with a GAPDH Ct value of 25 
or greater were excluded from further analysis. For conferring specificity of the 
endogenous OSKM transgenes, TaqMan assays for the endogenous OCT4, SOX2, 
KLF4 and c-MYC were directed against the 3’-UTR region of the transcript, since 
polycistronic viral OSKM transgene do not have UTR regions, and monocistronic viral 
OSKM transgenes contain synthetic UTRs. To test for the presence of the viral 
transgenes in monocistronic reprogramming, primers targeting the synthetic O,S,K and 
M UTRs were used for RT, Pre-Amp and analysis by SYBR green qPCR on an ABI 
7900HT. These primers are listed in (Supp) 
6.2.8 Marker panel selection 
 
Genes analyzed in this study include 48 markers used in our previous publication and 
an additional 48 genes selected based on curation of the current literature. These 
include markers of the pluripotent state, chromatin modifiers and lineage-specific genes. 
The role of these genes all have established roles in maintenance or establishment of 
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the pluripotent state, or have known functions in reprogramming. Fibroblast genes were 
selected based on their expression in fibroblasts and absence from hESCs as 
determined in [32,61]. 
6.2.9 Data analysis and computational Modeling 
 
qPCR data from the Biomark was binarized such that detected genes (Ct<35) and 
undetected genes were converted to 0 and 1 values, respectively. This dataset was 
then used for all subsequent analysis in R v3.0.1. We then developed a modeling 
pipeline to describe the expression changes occurring during reprogramming. First, we 
use PCA to reduce the data to two dimensions (PC1 and PC2) and we fit a polynomial 
regression curve to the data and define the reprogramming trajectory. We then project 
each cell to a point on the curve based on the shortest distance, providing a value for 
each call along the trajectory. The trajectory values are then scaled between 0 
(fibroblast) and 1 (hESC) for easier interpretation. To model expression of each gene, 
we use the binary data and reprogramming trajectory to fit a logistic regression that 
describes the probability of detection as reprogramming progresses. Bootstrapping the 
logistic fitting procedure 100 times and sampling with replacement to ensure robustness 
of the method created confidence intervals.  
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Chapter 7 Supplemental Figures and Tables 
7.1 Supplemental Figures 
7.1.1 Supplemental Figure 1 
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7.1.2 Supplemental Figure 2- Bubble Plots 
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7.1.3 Supplemental Figure 3-Violin Plot 
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7.1.4 Supplemental Figure 4 
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7.1.5 Supplemental Figure 5-Gene Expression Dynamics Using Gaussian Distributions 
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Figure S5: Modeling Gene Expression Dynamics Using Gaussian Distributions 
Models depict the observed detection frequency (grey dots) along the Reprogramming 
Progression Axis using a sliding window analysis as described in Methods. Red lines 
depict the model fit resulting from the underlying normal distribution (blue dotted line). 
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7.1.6 Supplemental Figure 6 
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7.1.7 Supplemental Figure 7 
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Figure S7: Modeling Gene Expression Dynamics Using Logistic Regression Models 
between MRC-5 and BJ fibroblast cells during reprogramming towards pluripotency. 
Red line shows gene expression dynamic of MRC-5 fibroblast cell, whereas blue line 
shows gene expression dynamics of BJ fibroblast cell. Each circle represent individual 
MRC-5 (Red) or BJ fibroblast cell (Blue) infected with polycistronic reprogramming 
vector. 
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7.1.8 Supplemental Figure 8 
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Figure S8: Modeling Gene Expression Dynamics Using Logistic Regression Models 
between monocistronic and polycistronic reprgramming cells moving towards 
pluripotency. Red line shows gene expression dynamic of Monocistronic, whereas blue 
line shows gene expression dynamics of polycistronic. Each circle represent individual 
cell infected with either mono-(Red) or polycistronic reprogramming vector (Blue). 
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7.2 Supplemental Table 
 7.2.1 Supplemental Table 1 
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7.2.2 Supplemental Table 2 
 
Gene Baseline Scale Mean Stdev AICC 
CBX7  0.052632 -0.10051 0.991556 0.016493 -7011.49 
CCND1  0.947368 0.100026 0.90085 0.112272 -6049.31 
CDH1  0 0.948792 0.515163 0.147273 -6367.52 
CDKN1A  1 -0.61862 0.882695 0.101018 -6707.1 
COL3A1  1 -0.38748 0.43193 0.098134 -6001.72 
DNMT3B  0 0.935446 0.607084 0.180596 -5600.2 
DNMT3L  0 0.100011 0.818973 0.026747 -8780.74 
EED  0.210526 0.460534 0.15776 0.112932 -6484.99 
ETV5  0.263158 0.100248 0.030285 0.009632 -4278.97 
FBXO15  0.105263 -0.1 0.622454 0.180596 -6545.29 
FOXD1  0.578947 0.133341 0.241371 0.069019 -4202.41 
GREM1  0.263158 -0.23747 0.368077 0.054695 -6266.1 
HDAC2  0.894737 0.105578 0.163729 0.144948 -9691.05 
HESX1  0 0.254509 0.895169 0.063659 -7838.06 
JARID2  0.631579 0.359664 0.188672 0.178532 -7099.61 
KAT7  0.947368 0.100034 0.690427 0.180596 -6692.84 
Klf4  0.631579 -0.10577 0.109557 0.055471 -5956.13 
LATS2  0.578947 0.141871 0.028376 0.012383 -4351.91 
LEFTY1  0.578947 -0.10029 0.138609 0.012123 -3633.38 
LEFTY2  0.052632 0.814088 0.292862 0.180596 
        -
6309.38 
LIN28A  0 0.8684 0.284766 0.180596 -4518.9 
LOX  0.947368 -0.39521 0.169431 0.11828 
        -
4560.11 
LUM  0.947368 -0.80084 0.32286 0.180596 
        -
6203.03 
MYC  0 0.163619 0.769866 0.171468 -7734.03 
NACC1  0.947368 0.100054 0.900837 0.113807 -6061.31 
NANOG  0.157895 0.837598 0.195052 0.139553 -7441.85 
NROB1  0 -0.10058 0.991556 0.012586 -8602.77 
Otx2  0.052632 0.766356 0.861305 0.110117 -7161.05 
PHC1  0.736842 0.198745 0.602832 0.013183 -3898.86 
POU5F1  0.157895 0.805615 0.370688 0.180596 -6094.48 
REST  0 3.65E-21 0.991556 0.009632 -99460.3 
RIF1  0.578947 0.362344 0.795243 0.059163 -4795.98 
RNF2  0.736842 0.243195 0.231981 0.180596 -7166.14 
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SALL1  0.894737 -0.11851 0.087099 0.025809 -6033.18 
SALL4  0 0.990657 0.522721 0.180596 -6078.84 
SET  1 0.100226 0.991556 0.012596 -8068.11 
SMARCC2  1 -0.10006 0.991556 0.012787 -7911.87 
SNAI2  0.894737 -0.80742 0.315916 0.180596 -6311.56 
SOX2  0.263158 0.436022 0.599727 0.180596 -6027.71 
SP1  0.894737 0.101535 0.354385 0.180596 -8395.92 
STAT3  0.947368 -0.10426 0.760637 0.06302 -7621.89 
TCF3  0.894737 -0.10068 0.028747 0.009632 -4920.81 
TDGF1  0.421053 0.445005 0.355582 0.180596 -5938.2 
TGFBR2  0.947368 -0.70933 0.55147 0.065972 -4894.66 
TRIM28  0.947368 0.052569 0.194608 0.180596 -10737.5 
ZFP42  0 1 0.556834 0.164067 -7508.61 
ZIC3  0 0.936096 0.754576 0.180596 -6585.11 
ZNF281  0.736842 0.225216 0.18891 0.108623 -7123.8 
 
 
Table S2: Parameters for Single Gaussian distribution Model 
 
7.2.3 Supplemental Table 3 
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7.2.4 Supplemental Table 4 
  
 
Supplemental Table 4: List 96 Taq-man Assay used in single cell qRT-PCR using Biomark instrument 
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7.3 Authored Papers 
 7.3.1 Single cell analysis reveals the stochastic phase of reprogramming to 
pluripotency is an ordered probabilistic process 
 
Chung K-M, Kolling FW, Gajdosik MD, Burger S, Russell AC, Nelson CE PLoS One. 
Public Library of Science; 2014;9: e95304. doi:10.1371/journal.pone.0095304 
Abstract: Despite years of research, the reprogramming of human somatic cells to pluripotency 
remains a slow, inefficient process, and a detailed mechanistic understanding of reprogramming remains 
elusive. Current models suggest reprogramming to pluripotency occurs in two-phases: a prolonged 
stochastic phase followed by a rapid deterministic phase. In this paradigm, the early stochastic phase is 
marked by the random and gradual expression of pluripotency genes and is thought to be a major rate-
limiting step in the successful generation of inducedPluripotent Stem Cells (iPSCs). Recent evidence 
suggests that the epigenetic landscape of the somatic cell is gradually reset during a period known as the 
stochastic phase, but it is known neither how this occurs nor what rate-limiting steps control progress 
through the stochastic phase. A precise understanding of gene expression dynamics in the stochastic 
phase is required in order to answer these questions. Moreover, a precise model of this complex process 
will enable the measurement and mechanistic dissection of treatments that enhance the rate or efficiency 
of reprogramming to pluripotency. Here we use single-cell transcript profiling, FACS and mathematical 
modeling to show that the stochastic phase is an ordered probabilistic process with independent gene-
specific dynamics. We also show that partially reprogrammed cells infected with OSKM follow two 
trajectories: a productive trajectory toward increasingly ESC-like expression profiles or an alternative 
trajectory leading away from both the fibroblast and ESC state. These two pathways are distinguished by 
the coordinated expression of a small group of chromatin modifiers in the productive trajectory, supporting 
the notion that chromatin remodeling is essential for successful reprogramming. These are the first results 
to show that the stochastic phase of reprogramming in human fibroblasts is an ordered, probabilistic 
process with gene-specific dynamics and to provide a precise mathematical framework describing the 
dynamics of pluripotency gene expression during reprogramming by OSKM. 
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